CEMEX, S.A.B. de C.V. (NYSE: CX) — Fifteen Years to Fix the Balance Sheet, Fifteen Months to Price It In

Research memo. Prepared 2026-07-21. Price reference ~$12.60/ADS (2026-07-20 close; AZI prints $12.49, ROIC $12.66 — a ~1.4% source discrepancy, immaterial to anything below). All figures USD unless marked MXN/EUR. Q2 2026 results are due Thursday 2026-07-23, after this memo’s data cutoff.

⚡ Kimi’s Take

The following is the author’s own subjective opinion and general information, not investment advice. The body of this report below carries no position; the analysis confines itself to facts, labeled interpretation, and embedded-expectations framing.

Verdict: HOLD / trim-into-strength. Cemex is a completed rerating with residual optionality, not a falling knife and no longer cheap. The defensible zone is ~6.0–6.5x EV/EBITDA on the 2027 Sprint number — roughly $11–14/ADS — versus the ~7.2x FY25 multiple the market already pays at $12.60. Below ~$11 the Sprint-plus-Mexico-inflection package gets interesting again; above ~$14 the market starts paying for a GCC/Holcim-bracket re-rate that hasn’t happened.

The shape the evidence supports: this is a high-beta Mexico proxy whose 15-year balance-sheet repair is genuinely complete (covenant leverage 1.63x at YE2025, IG restored 2024, dividend +40%, buyback live) and whose fundamental rerating is statistically finished — P/S 1.11x and P/B 1.37x sit at decade highs (~100th percentile of own history), EV/EBITDA 7.18x at the ~80th percentile, and at $12.60 the market pays its own 10-year median multiple for full 2027 Sprint delivery with zero further price move. The momentum evidence agrees the easy money is made: +162% from the April-2025 tariff-shock low to January 2026, +65% trailing 12 months, y1 Sharpe 1.74 — and now a flat six-month tape consolidating 8% off the May high while the Momentum factor fades. What is not priced is the second act: a re-rate toward the European tier (worth ~$1–5/ADS of multiple alone), post-2027 EBITDA compounding, and USMCA resolution (management excludes it from guidance — free option). What is short-able from here is the bear case entirely: top-decile P/S and P/B mean multiple and earnings compress together if Mexico’s government-spending-led recovery blips, the same double-compression that produced two −43% drawdowns in the last four years.

Conviction: medium. The single piece of evidence that would flip this bullish: two consecutive quarters of Mexican cement volume growth with the 10% January price increase sticking — that would make the Mexico inflection demand-real rather than budget-real, and the GCC/Holcim re-rate case starts underwriting itself. The single piece that would flip it bearish: a Mexico volume stall in Thursday’s Q2 print against the 2H26 federal budget, which converts the +47% Q1 Mexico EBITDA into a social-program sugar high and leaves a 7.2x multiple on a $3.0–3.1B EBITDA with no rerating cushion. Fixed the company, priced the fix — the next dollar of return has to be earned, not re-rated.

📈 Stock Price Action — Five-Year Event Map

Five years ago CX was a $7.86 stock (2021-07-20) on its way to $3.20 (2022-10-14, the five-year closing low). It then climbed, crashed twice on Mexican politics, and finally rerated +162% in nine months to a five-year high of $13.55 close / $13.67 intraday (2026-05-06). It now trades ~$12.60, ~8% off that high, within a 52-week range of $7.64–$13.67. The stock sits essentially on its 50-EMA (~$12.46) and ~10% above a rising 200-EMA (~$11.36), with the 50 above the 200. Trailing total returns to 2026-07-20: 1m −1.9%, 3m +4.3%, 6m ~0%, 12m +65.4% dividend-adjusted, 2y +108%, 5y +63%. Price moves below are FACT; driver attributions are INTERPRETATION.

The cycle read: two of the three big drawdowns were Mexico-macro events (#3, #4), and the big recovery legs were company-specific (#2 deleveraging, #5 transformation). The factor model says both remain in the price — ~48% of variance is factor-explained with Mexico country the largest loading, while 26% annualized idiosyncratic volatility is unusually large. This is a stock that trades as a Mexico proxy day-to-day but whose big legs get earned by Cemex itself.

Executive Summary

Cemex is a Mexico-headquartered global cement, ready-mix and aggregates producer — $16,132M revenue and $3,080M Operating EBITDA (19.1% margin) in FY2025, reported in US dollars under IFRS as a foreign private issuer (20-F/6-K; no 10-K/10-Q). Its economics are dominated by one franchise: Mexico generates ~27% of revenue but 46% of consolidated EBITDA at a 32.8% margin, built on ~50% national cement share, a retail bagged-cement model (~two-thirds of Mexican demand), brand captivity and the Construrama distribution network. The US (31% of revenue, 19.6% margin) is a ready-mix-led regional business with a growing aggregates node; Europe (24%, 15.0%) is an over-capacitated market where Cemex’s decarbonization lead (582 vs ~625 kg CO2/t, ~2.9M surplus EUAs through 2029) is becoming a regulatory moat as CBAM and the ETS free-allocation phase-out squeeze high-carbon supply.

The equity story has three layers. First, the completed repair: the 2007 Rinker acquisition ($14.25B, top-of-cycle, all-debt) took total debt to ~$19.25B by June 2009; fifteen years of deleveraging brought covenant leverage to 1.63x at YE2025 (2.26x on the company’s net-debt-plus-$2B-hybrids definition, vs a 1.5–2.0x stated target), restored investment grade (S&P BBB− March 2024, Fitch April 2024; Moody’s does not rate), and enabled the pivot to returns — dividend raised ~40% to $180M for 2026 and a buyback intent of up to $500M over three years (~$100M executed in Q1’26), within annually re-authorized $500M AGM envelopes that sat unused 2023–25. Second, the transformation: new CEO Jaime Muguiro (since 2025-04-01) delivered $200M of recurring Cutting Edge savings in 2025 against $179M of P&L restructuring costs ($183M cash severance — distinct figures), is targeting a $400M run-rate by 2027, and has framed a 2027 “Sprint” of $17.8B sales / $3.7B EBITDA / 47% FCF conversion. Q1’26 was the proof-of-concept print: record Q1 EBITDA $794M (+34%), Mexico EBITDA +47% with the first volume growth in six quarters. Third, the portfolio rotation: ~$3.5B of LatAm/EM divestments 2022–26 (DR at $950M with a $551M gain, Colombia partial exit announced at ~10x EBITDA) recycled into small US/European bolt-ons (Couch, Omega) — sell dear, buy cheap.

The tension this memo documents: growth is price- and cost-led, not volume-led (volumes fell in 4 of 5 segments in 2025), Mexico’s recovery is government-spending-dependent, and the market has already agreed with the story once — the stock is +65% over 12 months with P/S and P/B at decade highs. At $12.60, the embedded-expectations math says the market pays a median historical multiple for full Sprint delivery, leaving the re-rate and post-2027 growth as unpriced upside and the Mexico macro as the priced risk. The immediate checkpoint is the Q2 print on 2026-07-23.

Business Overview

Cemex, S.A.B. de C.V. (NYSE: CX ADR; BMV: CEMEX.CPO) is a vertically integrated producer of cement, ready-mix concrete, aggregates and “Urbanization Solutions” (admixtures and construction chemicals, mortars, asphalt, concrete products and related services), headquartered in San Pedro Garza García, Mexico, with ~38,900 employees. FY2025: revenue $16,132M (flat YoY), Operating EBITDA $3,080M (+1%, 19.1% margin), consolidated cement volumes 52.6Mt (+3%), ready-mix 42.9M m³ (−2%) (FY2025 20-F). It is a foreign private issuer filing 20-Fs and 6-Ks, presenting in US dollars since the FY2019 20-F under IFRS — there is no US-GAAP reconciliation and no DEF 14A; governance disclosure is Mexican-standard.

Footprint. At YE2025 Cemex operated 52 cement and grinding plants with 78.0Mt/yr installed grinding capacity: Mexico 28.2Mt (15 plants), Europe 21.2Mt (17), US 12.1Mt (8), SCA&C 9.8Mt (10), MEA 6.7Mt (2). Around the cement core sit 279 US ready-mix plants, 34 US cement terminals plus 11 deep-water import terminals, 225 aggregates quarries (112.0Mt produced in 2025, ~27-year reserve life), and in Mexico 108 distribution centers and 8 marine terminals whose coastal plants can export to the US and Caribbean (FY2025 20-F). Reporting segments were redefined in FY2025 to a regional structure: Mexico, United States, Europe (UK, France, Germany, Poland, Spain, Czech Republic, Croatia), MEA (Israel, Egypt, UAE), and SCA&C (Colombia, Puerto Rico, Nicaragua, Jamaica, Caribbean).

Segment economics — the portfolio in one table (FY2025, external revenue / Operating EBITDA / margin; FY2025 20-F):

The asymmetry is the business: Mexico produces 46% of EBITDA on 27% of revenue; the US produces 32% of EBITDA on 31% of revenue. Mexico’s margin (~33%) is roughly 1.7x the US margin and 2.2x Europe’s — the Greenwald moat map in the Competitive Position section is visible directly in this table.

Product mix (2025 external revenue): Mexico is cement-led (cement 57%, ready-mix 30%, Urbanization Solutions 10%, aggregates 3%) on a retail/bagged model — its top-5 distributors take only 14% of volume and 96% of cement is sold domestically. The US is downstream-led (ready-mix 55%, cement 24%, aggregates 15%) with vertical pull-through: US ready-mix buys most of its cement and aggregates internally. SCA&C is 78% cement; Europe mixes ready-mix 42%, cement 34%, aggregates 19%. Reference realized prices used in 2025 reserve estimates: cement $141.2/t, aggregates $17.6/t (FY2025 20-F). The US aggregates node is deliberately growing: Cemex describes itself as the ~6th-largest US aggregates producer (company-cited, Pit & Quarry basis — treat as a company claim), 54M short tons sold 2025 across ~90 sites at a 33% EBITDA margin and $9.1/ST cash gross margin vs pure-play averages of ~35% and ~$10.5/ST (VMC/MLM tier, per peer company disclosures), including 2 of the ~10 US mega-quarries (Balcones, TX) (CEMEX Day deck, 2026-02-26).

Sustainability as product line. Vertua lower-carbon products reached 63% of cement and 56% of ready-mix sales in 2025. Cemex Go, the digital channel, handles >63,100 customers and ~65% of global sales. Regenera (circularity/waste) repurposed >25Mt of waste in 2025 toward a 41Mt/yr 2030 target; alternative fuels are 32.1% of the fuel mix with ~$183M of claimed cost avoidance (FY2025 20-F).

Security structure. 1 ADS = 10 CPOs; 1 CPO = 2 Series A + 1 Series B shares, so 1 ADS = 30 underlying shares; 99.99% of share capital sits in CPO form inside a trust, and non-Mexican investors (including all ADS holders) hold CPOs/ADSs rather than shares directly (FY2025 20-F; 6-K 2026-06-05). Shares outstanding: 43,525M shares = 14,508M CPO-equivalents = ~1,450.8M ADS-equivalents at YE2025 (flat vs YE2024).

Recent operating momentum. Q1’26 (2026-04-23): record Q1 Operating EBITDA $794M (+34% YoY, +23% like-for-like), margin 19.8% (+3.3pp), sales $4,019M (+11%, +3% like-for-like), controlling net income $228M (−69% vs the DR-gain-flattered Q1’25 — underlying profit roughly doubled), Mexico EBITDA +47% to $453M (36.1% margin), cement volumes +1% to 10.2Mt, FCF from operations +$29M (~$300M better YoY in the seasonally weakest quarter), ~$100M of buybacks executed (Q1’26 PR exhibit, 6-K 2026-04-23). Management reaffirmed full-year high-single-digit EBITDA growth guidance (hypothesis, not fact).

Industry Dynamics

The Greenwald textbook holds. Cement’s high weight-to-value ratio caps the economic trucking radius — Cemex itself states most US cement sells within ~200 miles (~300km) of a plant; ready-mix is even more local (perishable, ~1.5-hour delivery window); aggregates move economically ~30–50 miles before freight doubles delivered cost (FY2025 20-F; aggregates freight economics per public industry data). The result: a globally fragmented industry (~4Bt/yr, thousands of producers) that resolves, basin by basin, into tight local oligopolies. Share-stability tests pass in Cemex’s core markets — Mexican cement shares have been essentially unchanged for decades, US regional positions move only by acquisition, Germany’s top-5 hold >95%.

Regional structures.

• Mexico (~27% of Cemex revenue): Cemex holds ~50% of national production and sales; Cemex + Holcim + Cooperativa Cruz Azul supply ~70% (UNAM IIEC, 2025-10-31, corroborated by Forbes México — independent of company disclosure). The only greenfield entrants in ~15 years are Fortaleza’s Yucatán mill (2020) and tiny Cementos Jaguar (2022); recent capacity news is brownfield — Holcim’s Macuspana expansion (completed 2025) and Moctezuma’s announced Tepetzingo expansion — arriving into a demand downturn. Watch item, not yet discipline-breaking. Market size ~47Mt (2025).
• US (31%): a set of regional oligopolies with an import fringe. 2025 shipments 114.1M short tons (−2% YoY, still 18% below the 2005 peak); imports ~27M ST = 24% of supply (Turkey, Vietnam, Canada ~70%; >20% enters via Houston/Galveston); domestic capacity roughly stagnant for a decade with no greenfield plants; industry mill-net revenue ~$17B (USGS-derived data, accessed 2026-07-21). Named competitors: Holcim’s spun-off Amrize (AMRZ), CRH, Buzzi, Quikrete/Summit, Heidelberg Materials. The import fringe is what keeps US cement from being a pure local monopoly — coastal and Gulf markets are contestable at ~24% import share; the moat is strongest inland.
• Europe (24%): consolidated at the top but structurally over-capacitated — EU+UK clinker capacity ~205Mt against demand of ~115–125Mt, top-5 players ~50%. Cemex expects ~20–30% capacity rationalization over the next decade, “led by large players” (CEMEX Day deck, 2026-02-26). The UK is import-contested (~2.7Mt of imports in 2025 from over-capacity Ireland/Spain/Greece).

Demand drivers. US: infrastructure is the strong leg — real infrastructure starts +14.4% in 2025 (4th consecutive up year), nonres +1.6% with office/data-center +35.4%, against single-family starts of 943k (−6.9%) (FY2025 20-F). IIJA funding is ~73% obligated but only ~43% spent — roughly half the construction dollars still ahead — but authorizations expire 2026-09-30 with a ~$166B Highway Trust Fund gap (reauthorization bill H.R. 8870 introduced May 2026, per Congress.gov). The ACA’s Spring 2026 forecast calls for US cement consumption −2.5% in 2026, turning positive in 2027, with the US–Iran war (started Feb 2026) lifting rates and darkening the private-construction outlook (ACA, 2026-04-30). Mexico: 2025 was a hard down year — construction output −5.9% real, federal budget cut −14% real, Cemex Mexico cement volumes −8% — followed by a Q1’26 turn as the Sheinbaum administration accelerated social programs (rural roads, housing); industry output was still −3.7% YoY in May 2026 with recovery expected in 2H26. The Mexican demand mix is remittance/self-build housing (resilient, informal) plus government infrastructure/social programs (cyclical with the federal budget and the sexenio pattern: year-1 austerity, mid-term ramp); nearshoring is real but slow. Europe: divergent — Spain +16% consumption, Germany +5.7%, Poland ~−2% — with renovation/energy-efficiency mandates supporting volumes more than new-build.

Marathon capital-cycle read. (a) US: supply-starved — stagnant capacity, permitting barriers, imports the only swing supply; pricing was disciplined until 2025 softened (Cemex US cement price −1%). Favorable. (b) Mexico: disciplined oligopoly adding measured brownfield capacity into weakness — neutral-to-watch. © Europe: chronic overcapacity meeting a regulatory guillotine — decarbonization costs are the mechanism forcing rationalization, Marathon’s “capital starvation via regulation.” (d) Cemex corporate: post-2008 Rinker over-leverage was the canonical industry capital-cycle disaster; current policy (capex $1,243M < D&A $1,291M, bolt-ons only, divestment-funded) is explicitly anti-cycle.

Decarbonization economics. Cement is ~7–8% of global anthropogenic CO2. Cemex’s Future in Action targets (SBTi-validated): −47% Scope 1 CO2 in cement vs 1990 by 2030; progress −34% by 2025. In Europe specifically, Cemex’s gross intensity is 582 kg CO2/t cementitious vs a ~625 industry average — ~5 years ahead of the Cement Europe roadmap — and it holds a surplus of ~2.9M free EUAs (company-estimated ~€200M value at €71/EUA; note EUA spot was €83.27 on 2026-07-20, so the company’s illustration understates current market value) expected to cover emissions through 2029. CBAM’s definitive regime went live 2026-01-01 (first official certificate price €75.36/t Q1’26); free allocation phases out 2026→2034. Cemex estimates EU producers hold a ~€9/t cost advantage vs average imports through 2030 (CEMEX Day deck — company estimates, not audited). INTERPRETATION: in Europe, decarbonization is primarily a supply-side moat mechanism, not a cost — the phase-out embeds a rising carbon cost into every producer’s marginal cost and into import-parity pricing via CBAM, raising the price floor for all and squeezing high-carbon plants toward closure, rewarding the lowest-carbon incumbent. In the US and Mexico there is no comparable carbon price (Mexico’s ETS Phase I to 2030 is expected immaterial per Cemex, unverified), so decarbonization there is cost/optionality, not moat.

Verdict: structurally good locally, cyclical globally. Transport economics plus permitting convert commodities into durable local pricing power — the financial signature (price up through volume-down years) is visible in Cemex’s own 2021–2025 data. The industry’s bad traits are demand-side: deep construction cyclicality (US volumes still 18% below the 2005 peak), government-budget dependence (Mexico’s sexenio; the US IIJA cliff of 2026-09-30), and weather. The 2021–2024 pricing supercycle has plateaued, not collapsed — but volumes fell in 4 of 5 segments in 2025, which means the model is currently running on price and cost discipline alone. That is more fragile in cement than in aggregates, because of the import fringe and Mexico’s new capacity.

Competitive Position

Applying Greenwald’s framework — local scale economies plus customer captivity, tested by share stability and margin persistence:

Where the moat is real. (1) Mexico nationwide cement — the strongest franchise in the portfolio. ~50% share stable for decades; ~two-thirds of Mexican demand is retail bagged cement for self-construction, where Cemex’s brand family (Tolteca, Monterrey, Maya, Anahuac) and the Construrama distribution network (>5,000 online-active stores, >45,000 SKUs) create genuine captivity that bulk markets lack. The 20-F itself lists the barriers: retail-network build-out cost and time, poor port infrastructure, mountains shielding interior markets from imports, ~2-year plant build times. The proof is in the margin: 32.8% EBITDA margin, 46% of group EBITDA on 27% of revenue. (2) Specific US regions — Texas/Southeast cement plus aggregates, anchored by mega-quarries (Balcones) and cement→ready-mix vertical integration (55% of US revenue is ready-mix, fed internally). The pull-through model is real; aggregates (permit-protected, ~30–50mi radius) is the structurally better node, which is exactly why the M&A pivot targets US aggregates bolt-ons. (3) European decarbonization leadership — an emerging regulatory moat (582 vs 625 kg CO2/t, long EUAs through 2029) as CBAM and the free-allocation phase-out raise rivals’ marginal costs.

Where it is closer to a price-taker. Coastal US cement vs seaborne imports (24% of US supply), UK cement vs imports, French ready-mix (buys cement from third parties), and aggregates outside its quarry radii. Switching costs in cement itself are modest (a spec commodity) but real in practice: a failed ready-mix pour is catastrophic for a contractor, so reliable just-in-time logistics and specification relationships matter. Cemex Go (65% of sales digital, NPS 75) is a service-layer attempt to convert commodity relationships into captivity — treat as incremental, not structural.

Versus the majors (peer framing from public filings and industry data): Holcim/Amrize and CRH are bigger and better-capitalized in North America; CRH’s connected-portfolio model and VMC/MLM’s pure-aggregates franchises earn structurally higher margins than Cemex’s US business (Cemex US aggregates cash gross margin $9.1/ST vs pure-play ~$10.5 — company-cited comparison). Cemex’s distinctive asset is Mexico — no global peer has anything like it — plus the European carbon-intensity lead over Heidelberg/Holcim. Its historical weakness, the weakest balance sheet of the majors post-Rinker, is now largely repaired (1.63x covenant leverage, BBB−), which removes the discount driver but also means the deleveraging-alpha story is played out (stock +106% TSR in 2025).

Verdict: the moat is real and durable in Mexico (scale + captivity + brand + geography, decades-stable share) and real but narrower in US Texas/Southeast aggregates-led vertical integration; it is emerging, regulation-manufactured in Europe; and it does not exist on the import-contested coasts. The margin ladder — Mexico ~33%, US ~20%, Europe ~15% — is the moat map. The investment-relevant implication: Cemex’s quality is concentrated in the segment most exposed to Mexican macro and politics, which is precisely why the stock trades as a Mexico proxy (Country: Mexico factor loading +1.07) rather than as a materials compounder.

Growth History & Forward Opportunities

History: a revenue plateau with price-led margin recovery. Revenue has been essentially flat since 2023 — $16,404M (2023) → $16,063M (2024) → $16,132M (2025) — while EBITDA recovered from the 2022 energy shock ($2,433M, 16.5% margin) to ~$3.1B and a ~19% margin for three consecutive years. Underneath the flat top line, volumes fell: in 2025 Mexico cement −8% and ready-mix −11%, US cement −3% and RMX −6%; growth came from price (Mexico cement +4% and RMX +6% in MXN terms; SCA&C cement +3%; MEA cement +45% on Egypt normalization) and later from cost (Cutting Edge). 2021’s 23.9% margin was a demand/price spike year; the three-year ~19% plateau is the more honest base (FY2025 20-F).

The inflection is Mexico. Q1’26 delivered Mexico EBITDA +47% to $453M at a 36.1% margin, with the first YoY cement volume increase in six quarters — driven by government social programs: the social housing program (1.8M-unit goal through 2030; Cemex participation doubled to 58,000 units under construction in Q4’25 with 105,000 more under negotiation), rural roads (Caminos Rurales, bagged-cement intensive), rail projects, and 2026 World Cup works (Q4’25 call, 2026-02-05; Q1’26 PR). Muguiro guided Mexico 2026 demand “no less than 2.5% to 3%” plus potential ~1pp infrastructure share regain (Q3’25 call — hypothesis). INTERPRETATION: the recovery is real but government-spending-led — the same driver that caused the 2025 slump (federal budget −14% real). Mexico demand durability is the single largest swing on the forward story.

2026 guide and the FX cushion. Guidance is high-single-digit EBITDA growth for 2026, built on (i) $165M incremental Cutting Edge savings ($125M from overhead actions already taken in 2025), (ii) $80M incremental EBITDA from completed growth projects, “half of which relies on volume recovery,” and (iii) an FX assumption of MXN 18.25–18.50/USD (Q4’25 call). Spot MXN is ~17.5 (July 2026 — sourced from a forecast site, directionally plausible but weak sourcing; treat with care). Management’s own disclosed sensitivity — “for every peso of appreciation… we can increase EBITDA by around $75 million to $80 million” (Q4’25 call) — implies ~$55–80M of mechanical upside to the guide at spot, which management has not absorbed. That is either conservatism or a cushion against the energy-cost deterioration flagged in April (energy/ton now guided up mid-to-high single digit on the Iran war, ~60% hedged — secondary-sourced call color).

2027 Sprint and beyond. The CEMEX Day (2026-02-26) medium-term framework: sales ~$17.8B and EBITDA ~$3.7B by 2027 (roughly 5% and 10% CAGRs), EBIT $2.3B, ROIC +170bps vs 2025, FCF-from-operations conversion 47% by 2027 (targeting 50% thereafter), and a goal of distributing 40–50% of available FCF by 2030 (company targets — forward-looking statements). Self-help levers with quantified ambition: the US kiln-efficiency program added 500k tons of domestic production in 2025 replacing imports, with a further 1M short tons targeted that “could be as high as 2 to 3 percentage points” of US cement margin (management hypothesis); AI quarry optimization at Balcones showing high-single-digit to low-teens yield gains; aggregates volumes guided +MSD for 2026 on Couch and Florida/Arizona expansions.

Growth-quality verdict. Growth since 2023 is price- and cost-led, not volume-led: flat revenue, margin recovered on pricing and then on savings, volumes negative in the two largest markets. What that means: the model depends on pricing discipline holding in local oligopolies (evidence: prices sticky through the 2025 volume downturn) and on management-manufactured savings ($200M delivered, $400M targeted). It does not yet depend on demand growth — which cuts both ways: upside if Mexican volumes and US infrastructure actually arrive, fragility if price discipline breaks (Houston/NorCal/Atlanta competitive pressure already produced sequential US cement price slippage in 2025). The first genuine volume leg — Mexico Q1’26 — is six weeks from its second confirmation. Treat the Sprint’s ~10% EBITDA CAGR as achievable-but-not-underwritten: roughly half the 2026 incremental bridge is cost actions already taken (high confidence), and half leans on volume recovery (the unproven part).

Financial Quality

Five-year P&L (USD M; FY2025 20-F and prior 20-Fs; EBITDA = Cemex’s Operating EBITDA definition):

*2023 continuing-ops NI crushed by a 90.9% effective tax rate on deferred-tax effects.

Earnings quality: normalize EBITDA, never reported NI. The multi-year NI series is heavily distorted. FY2025 reported NI of $960M contains +$566M of net discontinued-operations results (Dominican Republic gain +$551M; Panama loss −$63M and −$24M goodwill cancellation) against continuing-ops NI of only $404M — and even that carries $538M of impairment losses ($307M US goodwill + $123M Colombia goodwill + $92M PM&E) and $179M of Cutting Edge restructuring costs inside “other expenses, net” ($784M total vs $1M in 2024). 2024 contained +$163M Guatemala gain, −$119M Philippines loss, +$139M Neoris gain; 2022 had −$442M impairments. FX swings inside financial income/other moved from −$353M (2024) to +$232M (2025) — a ~$585M pretax swing unrelated to operations. The effective tax rate is meaningless year to year (90.9% → 6.8% → 48.8%, on Mexican deferred-tax recognition/derecognition); cash taxes ($178M in 2025 vs $343M in 2024) are far more stable. Recurring impairment/restructuring noise is a Cemex pattern, not an accident — a quality deduction in itself (FY2025 20-F).

Cash flow: the conversion gap is the story. CFO has run ~$2.0B for three years ($2,288M / $1,979M / $1,975M). Capex of $1,243M in 2025 splits $824M maintenance + $419M expansion — maintenance at ~64% of D&A means the asset base is held, not grown. Strict FCF (CFO − capex) was $732M in 2025, a ~24% conversion of Operating EBITDA (2023: 28%, 2024: 20%). That is well below the company’s own “FCF from operations” definition ($1.4B adjusted, 46% conversion in FY2025) and far below the Sprint target of 47% by 2027 / 50% thereafter. The ~23pp gap between strict and company-definition FCF is mostly working-capital timing, severance cash ($183M in 2025, lapsing), discontinued-ops noise and the definition of capex — but the strict number is what actually accumulates. Negative working capital structurally helps (cash conversion cycle ~−15 days). Q1’26 FCF from operations was +$29M, ~$300M better YoY in the seasonally weakest quarter — directionally encouraging, one quarter deep. INTERPRETATION: the FCF inflection is the least-proven leg of the equity story; conversion at ~24% strict leaves little room for error against a guide that requires ~45%+.

Balance sheet: repaired, with definitional care required. Total debt plus other financial obligations (incl. IFRS-16 leases and securitized receivables): $7,460M at YE2025, of which consolidated debt $5,644M; cash $1,822M. Net debt: $3,822M debt-only, $5,638M including leases/securitized obligations. Two company-stated leverage figures, both correct, different definitions — every quote must carry its tag: 1.63x = Consolidated Net Debt/EBITDA as calculated under the Credit Agreements (covenant basis; limit ≤3.75x; 1.81x at YE2024, 2.06x at YE2023), and 2.26x = (net debt + $2.0B subordinated notes)/EBITDA, the CEMEX Day slide-61 definition, against a stated steady-state target of 1.5–2.0x. Implied covenant net debt (~$5.0B) sits between the two balance-sheet figures; the line-item bridge is an open question. From ~4.15x net debt/EBITDA in 2019 and the ~$19.25B gross-debt peak of June 2009, the repair is complete: S&P BBB− (2024-03-13), Fitch BBB− (April 2024), Moody’s does not rate Cemex (NR per CreditSights 2025-03-04). Financial expense fell 17% to $454M in 2025; fixed-rate debt $4,261M at 4.8% average, variable $1,384M at 6.2%; maturity ladder is termed out through 2031+ ($1.5B 5.750% 2036 notes issued June 2026; €400M March-2026 notes refinanced with Ps5.5B CEBURES).

The hybrid wrinkle. $2,000M of subordinated notes (5.125% and 7.200%) are classified in equity under IAS 32 — their coupons ($127M in 2025) bypass interest expense entirely, flattering both reported financial expense and NI-based returns. Treat them as debt-like for credit analysis. One action item is dated: the remaining perp layer faces a September 2026 reset at 464bps over UST, which the CFO called “prohibitively expensive… one opportunity that we would like to address” (Q4’25 call). The June 2026 redemption of the $1.0B 5.125% subs (funded from the new $3.0B revolver) was step one.

Returns. ROE on controlling equity ~7.5–7.8% (2024–25) — un-flattered by the hybrids’ equity treatment but depressed by impairment noise. Operating ROIC for 2025 (NOPAT ~$1,430M on invested capital ~$19.0B, our estimate) is ~7.5% — likely near or just below WACC. That is the honest scoreboard: the franchise earns its cost of capital at the group level because Mexico (~33% margins) subsidizes Europe (~15%) and a subscale US position; management’s own shift to plant-level ROIC-over-WACC KPIs from 2026 is an admission that group-level averages hid the dispersion.

Verdict: do economics improve with scale? Only partially, and not in the usual way. Cemex’s scale advantage is local (plant-radius), not global; the last decade shows EBITDA margin recovering on price and cost discipline while revenue stayed flat and volumes fell — i.e., economics improved with discipline, not with scale. The structural return drag is the capital intensity (maintenance capex ~$0.8–1.0B/yr against ~$2B CFO) and a tax/FX/noise-heavy P&L. The bull version of financial quality is the strict-FCF conversion gap closing toward the Sprint’s 47%; the bear version is that ~7.5% ROIC is what this portfolio structurally earns, and impairments keep recycling through the P&L every 2–3 years.

Capital Allocation

The two eras. Cemex’s capital-allocation record cannot be summarized without splitting it. Era one is the original sin: a hostile all-cash offer for Australia’s Rinker Group launched October 2006 at ~$12.8B EV, raised to ~$14.25B for equity in April 2007, closed at the absolute top of the US housing cycle, financed almost entirely with debt against pre-deal net debt of only ~$5.1B. Total debt peaked at ~$19.25B on 2009-06-30; the August 2009 Financing Agreement restructured ~$14B of bank debt with covenants that dictated capital allocation for a decade. Era two is the repair: gross debt $19.25B (2009) → $6.78B (2025), covenant leverage 2.84x (YE2022) → 1.63x (YE2025), IG lost in 2008–09 and regained March/April 2024 — a ~15-year round trip. The 2009–2016 phase was coerced (covenant-restricted dividends, buybacks, capex); the post-2017 phase was elective — leverage kept falling after covenants loosened, the company sold crown-adjacent assets (Kosmos $665M/2020, Fairborn ~$400M/2017) rather than issuing equity at distressed prices, and it refused to re-lever into the 2021–22 upcycle. The consistency across two CEOs (González was CFO through the crisis, then CEO 2014–2025) indicates institutionalized discipline. The counterweight stands: the discipline was necessitated by management’s own error, which destroyed roughly a decade of equity value.

M&A record 2021–2026: buy cheap, sell dear, shift mix. ~$3.5B+ of announced divestments — Costa Rica/El Salvador $325M (2022, +$240M gain), Neoris (2022–24, +$139M), Guatemala $212M to Holcim (2024, +$163M), Philippines $798M (2024, −$119M after goodwill), Dominican Republic $950M (Jan 2025, +$551M gain), Panama $200M (Oct 2025, ~12x, −$63M loss), Colombia partial exit ~$555M at ~10x 2025 EBITDA ($485M to Holcim; announced 2026-03-12, closing expected end-2026) — recycled into small, cheap, developed-market bolt-ons: Couch Aggregates (49%→79% for ~$46M all-in, “high single-digit multiple after synergies”), Omega Products International (~$23M EBITDA stucco/mortar, synergies ~50% of target EBITDA per secondary call summaries, <7x post-synergy), RC-Baustoffe Berlin (recycling), a $29M Tampa aggregates terminal. Nothing acquired is large enough to impair the balance sheet; the two realized losses (Philippines, Panama) were exits from structurally challenged positions against goodwill-heavy carrying values. Divest-at-10x while the equity trades at ~7x is mechanically accretive and management demonstrably knows it.

Shareholder returns: more promise than track record, inflecting now. Dividends: none FY2009–FY2018 (verified 2016–18, inferred earlier), a one-off $150M in 2019, none 2020–23, then structural resumption — $120M (2024) → $130M (2025) → $180M declared for 2026 (+40%; 4 × $45M, first installment paid 2026-06-18, no Mexican withholding from CUFIN). Payout is ~18% (2025) to ~25% (2026 declared) of FY2025 strict FCF of $732M — deliberately conservative, and not the 8–11% that ROIC’s corrupt $1.71B FCF field would imply. Buybacks: the AGM has authorized a $500M envelope every year since 2023 — but zero shares were repurchased in 2023, 2024 or 2025 (20-F Item 16E). Actual history is trough-timed and accretive: ~$83M in 2020 (bought at ~$0.22/CPO-equivalent, cancelled) and $110.9M in 2022 (220.6M CPOs at $0.5026 weighted average, cancelled) — then nothing while the stock re-rated. The current program is company-stated intent of up to $500M over the next three years, subject to annual shareholder approval (~$167M/yr run-rate intent), within the annually renewed $500M authorizations; execution began 2026-02-10 with ~$100M deployed by Q1’26 (~78.8M CPOs ≈ 0.5% of capital). Whether the pace continued after February is unknown until the Q2 print. Net share-count shrink over six years: ~4% — real but modest; not yet a systematic shrink story.

Capex and refinancing. Total capex $1,243M in 2025 (0.96x D&A), split $824M base / $419M expansion, tilted US ($531M); ~$1,100M of commitments for 2026; decarbonization capex ~$210M/yr (~17% of total). June 2026: $1.5B 5.750% senior notes due 2036 issued at IG economics, the $1.0B 2021 Credit Agreement repaid, and the $1.0B 5.125% subordinated notes called (redeemed 2026-06-26) — terming out the stack and sacrificing some rating-agency equity credit to cut a perpetual coupon, a per-share-driven decision.

Incentives and governance. Comp design is better than comp disclosure: annual cash bonus (~4,500 executives) historically on Cash Value Added with a CO2 modifier, transitioning from 2026 to EBIT + FCF + CO2 with a TSR modifier; the senior-exec LT plan pays 0–200% on 3-year relative TSR vs seven global peers and the MSCI EM LATAM index. Aggregate board + senior-management pay: $56M paid / $60M granted in 2025 — no individual named-executive disclosure (FPI standard; no DEF 14A, no CD&A). The board is 83% independent under Mexican criteria — BUT the chairman is Executive Chairman Rogelio Zambrano Lozano (a relative also sits on the board), insiders hold just 2.82% economically, and control is structurally anchored: Series A votes underlying non-Mexican-held CPOs (i.e., all ADS holders) are directed by the CPO trustee in line with Mexican-held A shares, and by-laws require board pre-approval for any ≥2% stake acquisition — a hard anti-takeover device. Minority ADR holders are structurally passengers. Section 16 insider reporting for officers/directors began only 2026-03-18 (HFIAA); sampled Form 4s are small, compensation-related grants — no selling signal, thin data.

CEO transition. Fernando González (35+ years, the architect of the repair) retired; Jaime Muguiro (25+ years at Cemex, ex-President of Cemex USA) took office 2025-04-01 and immediately launched Cutting Edge, decentralized P&Ls, plant-level ROIC reviews, and a micro-market portfolio review with turnarounds-or-exits. Read: continuity-with-intensification, not a strategic break — González’s framework executed with a more operational, cost-and-returns-focused style, and faster portfolio churn.

Verdict. Two eras: a world-class capital-allocation recovery — 15 years of deleveraging without a dilutive raise, trough-timed buybacks that were actually cancelled, disciplined sell-dear/buy-cheap rotation — sitting on top of a poor long-horizon record created by one catastrophic 2007 decision. The 2026 step-up (dividend +40%, first buyback in three years) is the first year the “returner of capital” identity has real scale; whether it is a regime or a moment is the key thing to watch through 2026–27, and the governance structure offers minorities weak recourse if discipline slips.

Changes & Headwinds — Last Two Years

What changed (strengthening):

• CEO transition (2025-04-01). González → Muguiro, with continuity of strategy and an intensified operating cadence — regional P&L ownership (“The center is here to serve the line”), plant-level EBIT/FCF/ROIC KPIs tied to comp from January 2026, and a micro-market portfolio review. Morgan Stanley’s analyst framed it on the Q4 call: “you’ve not only driven this very strong operational turnaround, but you’ve also reshaped the narrative.”
• Project Cutting Edge. $200M of recurring savings delivered in 2025 (vs initial $150M target), $400M run-rate targeted by 2027, ~$165M incremental guided for 2026, ~45% of Q1’26 incremental like-for-like EBITDA. The cost of the savings: $179M of restructuring charges in the FY2025 P&L (20-F note 8) and $183M of cash severance payments (Q4’25 call) — distinct figures, do not conflate; the cash outflow lapses as a 2026 comp tailwind.
• Capital returns activated. Dividend +40% to $180M (2026), buyback intent of up to $500M over 3 years with ~$100M executed in Q1’26 after three dormant years.
• Credit repositioning. IG recovered (S&P 2024-03-13, Fitch April 2024); S&P affirmed BBB− (2025-03-27, again 2026-02); $1.5B 5.750% 2036 notes and a $3.0B sustainability-linked revolver (June 2026); 5.125% hybrid layer called. FY25 interest expense fell $160M.
• Portfolio rotation at good prices. DR ($950M), Panama (~12x), Colombia announced (~10x, $555M), Couch consolidated, Omega acquired.
• Mexico inflection. Q1’26 Mexico EBITDA +47%, first volume growth in six quarters, 10% price increase effective January 2026.
• ESG/regulatory positioning. MSCI ESG upgraded A → AAA (2026-03-24); European CO2 intensity 582 kg/t vs ~625 industry average, ~2.9M EUA surplus through 2029.

What changed (weakening or watch):

• Q4’25 $430M goodwill impairment ($307M US + $123M Colombia; total impairments $538M incl. PM&E) — the third material impairment year in four ($442M in 2022, $122M in 2024). The US charge, driven by higher discount rates and lower projected cash flows, is an implicit admission that parts of the retained Rinker-era US asset base still underperform carrying value. It says as much about past capital deployment as any divestment gain says about current skill.
• Energy-cost language deteriorated Feb → Apr 2026. Q4’25 call: “fuels… down; it is electricity where we see the increase.” Q1’26 (secondary-sourced): energy cost per ton now guided up mid-to-high single digit on the Iran war, ~60% hedged — a genuine guidance-language deterioration, with the FY HSD guide nonetheless kept. Q2 is the test.
• USMCA joint review not renewed (2026-07-01). USTR: “The United States did not agree to renew the USMCA in its current form… the Agreement remains in force pending resolution of these issues.” Third bilateral round scheduled the week of July 20. Management explicitly excludes any USMCA resolution from 2026 volumes — so resolution is asymmetric upside, but non-resolution prolongs the freeze in Mexican industrial/nearshoring investment Muguiro described. The 20-F flags an “adverse turn” scenario ranging to “partial or full dissolution.”
• EC antitrust Statement of Objections (6-K, 2026-07-21). Cemex received an SO in the construction-chemicals (admixtures) investigation opened in 2023, relating to admixtures activity in France and Germany. Cemex states its European admixture production is primarily for internal consumption with “insignificant” third-party sales, disagrees with the preliminary findings, notes an SO is not a final conclusion, and states that as of July 20, 2026 it cannot assess the likely outcome or whether a material adverse impact would result. Characterize it exactly that way: a live regulatory proceeding of unquantifiable outcome in a product line the company describes as having insignificant third-party exposure — not a major liability, not nothing. Even a hypothetical $200–300M fine would be ~1% of market cap.
• US volume stagnation. Three consecutive years of US cement volume declines; competitive pricing pressure in Houston, Northern California and Atlanta produced sequential price slippage in 2025; ACA forecasts −2.5% US consumption for 2026.
• Moody’s does not rate Cemex (NR per CreditSights, 2025-03-04) — two of three major agencies only; withdrawal circumstances unresolved.

Verdict: the two-year change ledger strengthens the thesis materially — management, cost structure, balance sheet, returns policy and portfolio mix all improved — while the headwinds (energy, US volumes, USMCA limbo, EC SO) are real but either hedged, guided-around, or small. The one genuinely new fundamental concern is what the US goodwill impairment implies about the durability of the US earnings base the 2026 guide leans on. Net: the company exits the window stronger than it entered; the risks have migrated from the balance sheet to the demand side and to Mexico politics.

Risk Analysis

Verdict: the risk profile has rotated from financial (leverage, refinancing — now largely retired) to macro and political. The dominant risk is not company-specific: CX is a Mexico proxy first, and the two biggest drawdowns of the last four years were Mexico-politics events, not earnings events. Company-specific risks are second-order: a dated, telegraphed hybrid reset; a quantifiably small EC exposure; and a price-led model that needs at least one of Mexico volumes or US infrastructure to keep the bridge honest.

Valuation

All multiples hand-computed on $12.60 × 1,450.8M ADS-equivalents. Data-quality note: ROIC.ai’s market cap/EV fields for CX are corrupt (~16x too high — a $300.6B phantom market cap from multiplying raw share count by ADS price), and AZI’s valuation_index percentiles are garbage for the same ADR share-count disease (implied ~152M share base). Neither vendor’s derived fields are used anywhere below; the own-history percentile series was rebuilt from AZI year-end prices × correct ADS-equivalent shares + net debt against 20-F fundamentals.

Multiples at $12.60. Market cap ~$18.28B. EV ~$22.1B (net debt ex-leases $3,822M) to ~$24.2B fully loaded (net debt + obligations $5,638M + NCI $308M). EV/EBITDA 7.18x FY25 ($3,080M) / 6.73x TTM ($3,282M) / ~6.7x 2026E (~$3.3B), debt-only; ~7.9x/7.4x/~7.3x fully loaded. P/E 19.0x FY2025 reported EPS ($0.663/ADS — inflated by the DR gain); ~45.8x on continuing-ops EPS ($0.275/ADS — impairment-burdened, overstates the clean multiple); ~40x TTM; ~16–17x on normalized 2026E EPS of ~$0.72–0.77 (our normalization: EBITDA ~$3.3B − D&A $1.29B − other ~$100M − financial expense incl. hybrid coupons ~$420M, 25–30% tax; hard lower bound: Q1’26 NI ×4 = $0.63, 20.1x, on the seasonally weakest quarter). P/S 1.11x TTM. P/B 1.37x (BVPS $9.07/ADS). FCF yield: 4.0% strict (CFO − capex $732M), ~7.7% on the company’s adjusted definition ($1.4B), ~8.1% on 2026E guided conversion, 9.5% if the 2027 Sprint lands — against today’s market cap. Dividend ~1.0% + buyback ~0.9%/yr at the 3-year envelope pace (up to ~3.7% total if the full $500M ran annually, which the stated 3-year intent does not imply).

Own-history percentiles — the rerating is statistically complete on sales and book (year-end prints, rebuilt series):

Ten-year medians: EV/EBITDA 6.57x, P/S 0.64x, P/B 0.89x. Current P/S and P/B are at the decade high (~100th percentile); EV/EBITDA at the ~80th percentile of own year-ends (~70th on TTM). EV/EBITDA looks less extreme only because EBITDA itself grew ~27% off the 2022 trough — the market is paying a premium multiple on recovered earnings, the classic late-rerating signature. The only historical headroom is the 2016 print (9.85x, pre-repair narrative, sub-3x leverage).

Comps — three tiers, and CX has moved up one. US materials: AMRZ 13.4x EV/EBITDA, CRH 15.0x, VMC 17.5x, MLM 19.1x (ROIC TTM to 2026-03-31). European integrateds: Heidelberg ~7.4x (July 2026), Holcim ~9–10x (3-yr avg 9.6x, secondary aggregators — flag middling freshness). Mexico read: GCC 7.9x (2025-06-30 — 12 months stale; if the Mexico bid lifted GCC with CX, the current comp may be higher). CX at 6.7–7.4x TTM now trades at par with the European tier (par with Heidelberg, ~1 turn under GCC, ~2–3 turns under Holcim) and at a ~50–60% discount to the US tier. The historical leverage excuse for the discount is dead — at 1.63x covenant leverage (2.26x including hybrids) the balance sheet is no longer an outlier vs Heidelberg (~1.5x). The residual discount is the Mexico-proxy/governance discount: the factor evidence (Country: Mexico +1.07 loading; nearest factor peers are Mexico ETFs, not cement names) says the market prices CX as a Mexico macro vehicle with a cement overlay, plus governance (family executive chair, CPO vote-stripping, 2% bylaw) and structurally lower FCF conversion. Re-rate arithmetic: at GCC’s 7.9x on TTM EBITDA the equity is ~$19.9B (~$13.7/ADS); at Holcim’s ~9.5x, ~$25.3B (~$17.4/ADS); the US tier is not a sane underwriting frame (~$33/ADS at CRH’s 15x). The Colombia deal is a live arb of this discount — selling SCAC assets at ~10x while the equity trades at ~7x.

Embedded expectations — what $12.60 already pays for. (a) EV/EBITDA path: if the 2027 Sprint lands ($3.7B EBITDA), today’s EV compresses to 5.97x (debt-only) with zero price move — i.e., at $12.60 the market is paying roughly its own 10-year median multiple (6.57x) for full Sprint delivery. Holding 7.2x on $3.7B with post-Colombia net debt implies ~$14.1/ADS (+12%). Growth beyond 2027 priced at $12.60: essentially none on this lens. (b) FCF framing: at a 10% equity discount rate and 2.5% terminal growth, the $18.28B cap requires FCFE of ~$1.0B in 2026, ~$1.3B in 2027, and a ~$1.5B steady state from 2028 — exactly the Sprint’s 47% conversion delivered and held (at 9% the requirement falls to ~$1.34B; at 11% it rises to ~$1.69B). The market only wins from here if conversion holds near 50% into 2028–30, EBITDA compounds past $3.7B, or the Mexico discount rate falls below 10%. © Itemized: the price assumes Mexico recovery durability (a slip back to FY25 Mexico EBITDA is a ~$200–300M EBITDA swing ≈ ~$1.0–1.5/ADS at 7x), the HSD 2026 guide, Colombia closing at ~$555M (~2.3% of EV), no material EC fine, and ~$167M/yr of buybacks. It does not assume a US housing recovery (ACA −2.5% 2026; management sees single-family recovery in 2027), USMCA resolution, a re-rate toward the GCC/Holcim bracket (worth ~$1–5/ADS of multiple alone), or any post-2027 growth. The peso cushion (guide FX 18.25–18.50 vs ~17.5 spot ≈ $55–80M EBITDA by management’s own sensitivity) is partially priced conservatism.

Scenarios — framing what $12.60 pays for in each (not targets).

Immediate checkpoint. The Q2 2026 print on Thursday 2026-07-23 (11:00 ET) tests the base case the price already assumes: Mexico volume durability against the 2H26 budget, energy-cost language, US price realization after the April 1 $8/t increase, buyback pace post-February, and whether the HSD guide gets raised toward the peso. No price target is set in this memo; the framework above states what the current price already requires.

Variant Perception

Where consensus sits. The sell-side is split: a Hold-leaning consensus (an 11-analyst average target of ~$10.14 per AInvest, April 2026 — three months stale and a low-reliability aggregator; use for dispersion only, not as a number) versus Morgan Stanley Overweight at ~$14–14.75. The bracket (~$10.14 / $12.60 / ~$14.75) maps almost exactly onto this memo’s bear-mid / base / base-high framing — the sell-side debate and the embedded-expectations math are having the same argument: is the Sprint worth paying a median historical multiple for in advance?

The core tension. “Rerating done” versus “re-rate to European par.” The done camp has the stronger statistical evidence: P/S and P/B at decade highs, EV/EBITDA at the ~80th percentile, +65% over 12 months, six-month tape flat. The re-rate camp has the structural argument: the leverage excuse for CX’s discount is dead (1.63x covenant), and at par with Heidelberg (~7.4x) the market is still charging CX a Mexico/governance discount worth ~$1–5/ADS against the GCC/Holcim bracket. Both can be true simultaneously: the rerating of the repair is complete, while the rerating of the identity (from leveraged EM cement proxy to normal European-tier integrated) has not started. The factor evidence adjudicates: CX’s nearest factor relatives are Mexico ETFs (EWW 0.82 cosine similarity) and Mexican cyclicals, not cement names — the identity re-rate requires the market to stop pricing Mexico first, which is not Cemex’s to deliver.

Factor and positioning read. Country: Mexico +1.07 loading, Market +0.81, idiosyncratic vol 26% annualized (unusually large company-specific overlay), y1 Sharpe 1.74. Regime: Value and DividendYield factors in favor (z +1.4 to +1.7), Momentum fading (21d z −0.79), Materials sector out of favor (z ≈ −1.1). Positioning is clean: short interest 0.8%, no squeeze dynamics, liquid institutional tape with reported 13F accumulation. The 12-1m momentum (+65% 12m, ~0% 6m) is decelerating — the easy-agreement phase has paused, but there is no negative-Quality-riding-momentum pattern that would flag mean-reversion risk.

Bull case. Mexico’s inflection is durable (social housing 58k units under construction + 105k in negotiation, rural roads, World Cup, nearshoring unfreezing on USMCA resolution — which management excludes from guidance, making it pure upside); US infrastructure meets a starved supply side with the April $8/t price increase sticking; CBAM-era European pricing power (management targets MSD increases 2026–28; Cemex long ~2.9M EUAs through 2029 with a ~€9/t cost advantage vs imports — note the company’s €71/EUA assumption vs €83.27 spot flatters the surplus value); Cutting Edge reaches the $400M run-rate; Sprint lands at $3.7B EBITDA with 47% conversion; and the identity re-rate carries the multiple toward 8.5–9.5x → ~$19.7–22.5/ADS framing.

Bear case. Mexico’s recovery is a social-program sugar high that stalls against the 2H26 federal budget; the peso reverses from ~17.5 toward 19+ (each peso = $75–80M EBITDA); the ACA’s −2.5% US forecast extends into 2027 through the IIJA cliff; energy reflation from the Iran war sticks; price discipline cracks in contested US markets; and the multiple mean-reverts to the 2023–24 band (4.5–5.5x) on flat EBITDA → ~$5.3–7.7/ADS framing. At decade-high P/S and P/B, there is no rerating cushion: in the bear case the multiple and the earnings fall together, as they did twice in the last four years.

The 3–5 assumptions that matter most: (1) Mexico recovery durability — 46% of EBITDA; Q1’s +47% must survive the 2H26 budget. (2) Sprint delivery — $165M Cutting Edge + $80M growth projects in 2026, $3.7B EBITDA and 47% conversion by 2027. (3) US volumes — IIJA reauthorization by 2026-09-30; ACA’s 2027 turn positive. (4) The peso — the guide’s 18.25–18.50 assumption vs ~17.5 spot is the single biggest mechanical swing. (5) Buyback continuation — whether the ~$100M Q1 pace persisted after February; the returns identity depends on it.

Falsification evidence. For bulls: two consecutive quarters of Mexican volume growth with the January 10% price increase sticking; HSD guide raised on peso at Q2 or Q3; buyback pace ≥ ~$100M/quarter confirmed. For bears: Mexico volumes flat-to-down in Q2 against easy comparisons; energy costs overriding Cutting Edge savings in the margin bridge; US cement price realization negative post-April; the buyback quietly paused after the February tranche.

Catalysts (dated): Q2 print 2026-07-23; IIJA authorization expiry 2026-09-30; subordinated-notes reset September 2026; Colombia closing expected end-2026; USMCA bilaterals ongoing (week of July 20 round).

Fact vs. Interpretation

Open Questions

From the log’s UNRESOLVED ISSUES, in order of materiality:

1. Driver of the Jan 28 → Mar 20, 2026 −24% correction — no confirmed attribution (candidates: FX-flattered Q4’25 print reaction, broad risk-off, Mexico tariff overhang).
2. Buyback pace after 2026-02-26 — daily 6-Ks stop there; Q2 print (2026-07-23) is the checkpoint. Did the program pause after ~$100M?
3. Q1’26 covenant leverage and capex guide — the Q1 report’s leverage/buyback tables are image-based; not independently captured. Q2 6-K will carry updated figures.
4. Covenant net-debt bridge — implied covenant net debt ~$5.0B sits between debt-only ($3,822M) and incl.-obligations ($5,638M); line-item reconciliation not reproduced.
5. Severance isolation — $183M cash severance (call) vs $179M P&L restructuring (note 8) reconciled at concept level; exact cash/P&L mapping not line-item verified.
6. EC antitrust fine quantum — unquantifiable at SO stage; the company itself states it cannot assess outcome or materiality.
7. Mexico ETS Phase-I free allocation — Cemex expects no material impact; unverified, rules effective H1-2026.
8. Moody’s NR history — confirmed only that Moody’s does not currently rate Cemex; withdrawal date/circumstances unknown.
9. Q1’26 call color is secondary-sourced — energy hedging (~60%), guidance rationale wording, Omega synergy detail rest on Alpha Spread/MENAFN/TipRanks summaries; no primary transcript available (ROIC carries CX only through Q4’25). Numbers are PR-verified; color is not.
10. Spot MXN sourcing — the ~17.5/USD reference rests on a forecast site; the FX-tailwind math should be re-based on a primary FX source before reliance.

What Must Be True

For the bull case (~$19.7–22.5 framing) to be right:

• Mexico’s volume recovery must be structural, not budgetary — volumes growing into 2027 even as the social-program impulse fades, with the 10% January 2026 price increase sticking. Falsification test: Mexican cement volumes flat-to-down YoY in either of the next two quarters, or price/mix turning negative in the Mexico segment disclosure.
• The Sprint must deliver — EBITDA ≈ $3.7B and FCF conversion ≈ 47% by 2027, with strict-definition FCF (currently $732M, ~24%) visibly closing the gap toward the company definition. Falsification test: 2026 EBITDA tracking below ~$3.3B (the HSD guide) at the half-year mark, or conversion guidance slipping below 45%.
• The market must start pricing CX as a cement company rather than a Mexico ETF — factor loading on Country: Mexico declining, multiple migrating toward the GCC/Holcim bracket. Falsification test: the Mexico discount widening (multiple de-rates vs Heidelberg/GCC peers) despite Sprint-track delivery.

For the bear case (~$5.3–7.7 framing) to be right:

• The price-led model must exhaust — volumes still falling in Mexico and the US while pricing stops covering cost inflation (energy reflation unhedged beyond ~60%). Falsification test: consolidated volumes positive for two consecutive quarters with price/cost spread still positive — the model then has a volume leg and the exhaustion thesis is wrong.
• The peso must reverse materially toward or past the 18.25–18.50 guide assumption. Falsification test: MXN holding ≤17.5 through year-end with the guide raised on FX — the translation tailwind then compounds instead of reversing.
• The returns pivot must prove cosmetic — buybacks paused after the February tranche, Colombia proceeds absorbed by something other than returns/bolt-ons. Falsification test: confirmed continued buyback execution at ≥ ~$100M/quarter plus Colombia closing at ~$555M by end-2026 with proceeds directed to stated priorities.

Prepared 2026-07-21. All claims trace to the primary sources cited in Appendix B — the FY2025 Form 20-F, earnings 6-Ks, earnings-call transcripts, and company presentations; management commentary is labeled as hypothesis where it appears. No recommendation is made in the body of this report.

APPENDIX A — Standard Diligence Questionnaire — CEMEX, S.A.B. de C.V. (NYSE: CX)

Prepared 2026-07-21. All answers are grounded in the primary sources listed in Appendix B: FY2025 Form 20-F (filed 2026-04-24), Q1’26 earnings 6-K (2026-04-23), Q2/Q3/Q4-2025 earnings-call transcripts, CEMEX Day 2026 deck (2026-02-26), and 6-K filings through 2026-07-21. Labels: [F] fact, [I] interpretation, [A] assumption. Q2 2026 results are due 2026-07-23 — after this appendix was written. This appendix contains no recommendations and no price targets.

1. General

What thoughtful questions have other investors asked?

The 2025–2026 earnings-call Q&A record shows institutional investors converging on six questions, each of which maps to a genuine uncertainty rather than boilerplate:

• Sprint credibility. Management’s CEMEX Day 2026 “Sprint” targets — sales ~$17.8B, EBITDA $3.7B (+~10%/yr), EBIT $2.3B, 47% FCF-from-operations conversion, ROIC +170bps by 2027 — require EBITDA to compound at a rate Cemex has never sustained outside a demand spike. [F] Analysts pressed on the bridge: $165M incremental Project Cutting Edge savings in 2026, ~$80M from completed growth projects (half volume-dependent), and low-single-digit price/volume assumptions. [F] The skeptical framing (visible in the sell-side split — an 11-analyst Hold-skew consensus vs. Morgan Stanley Overweight) is whether a cost program plus price-led recovery can deliver a demand-cycle-sized result. [I]
• Mexico durability. Mexico is 46% of consolidated EBITDA on 27% of revenue. Q1’26 Mexico EBITDA rose 47% to $453M (36.1% margin) on government social programs (social housing, rural roads) after a -8% cement-volume year in 2025. [F] The recurring investor question: does the recovery survive the second-half-2026 federal budget reality, or is it a social-program blip in a sexenio cycle (year-one austerity, mid-term ramp)? [I]
• Buyback pace. ~$100M of CPOs were repurchased in the first twelve trading days of the program (Feb 10–25, 2026) against a stated intent of up to $500M over three years (subject to annual shareholder approval; the AGM envelope is $500M/yr). [F] Investors asked, in effect: is the front-loaded pace sustainable, and did it continue after February? No daily 6-Ks exist after 2026-02-26 — the Q2’26 print is the checkpoint. [F]
• Energy hedging and the Iran war. Between the February and April 2026 calls, energy language deteriorated: from “fuels down, electricity up” to energy cost per ton of cement up mid-to-high single digit in 2026, with ~60% of 2026 energy exposure reportedly hedged (secondary-sourced; Q1’26 call transcript unavailable). [F/A] Guidance was kept unchanged despite a 34% EBITDA beat, explicitly citing Iran-war energy uncertainty. [F]
• Hybrid (subordinated notes) reset. CFO Al-Haffar flagged the September 2026 reset on the subordinated perpetuals at 464bps over UST as “prohibitively expensive” and an item to address; the June 2026 redemption of the $1.0B 5.125% hybrid was part of the answer, and replacement of the raters’ equity credit remains “under evaluation.” [F]
• USMCA. The July 1, 2026 joint review ended without renewal (“remains in force pending resolution”); management has repeatedly framed USMCA resolution as volume upside excluded from guidance, and non-resolution as prolonging the freeze on Mexican industrial/nearshoring investment. [F/I]

2. Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Neither cleanly — the composition matters more than the level. FY2025 EBITDA margin of 19.1% is near records and Q1’26 margin of 19.8% (+3.3pp YoY) is a Q1 record, but volumes remain below peak: US cement shipments are still 18% below the 2005 peak and fell three consecutive years; Mexico cement volumes fell 8% in 2025. [F] This is a price-led recovery — prices rose in local currency in every region in 2025 while volumes fell in four of five segments — which means earnings quality rests on pricing discipline holding, not on demand strength. [F/I] Regionally the cycle is desynchronized: Mexico is early-cycle (Q1’26 was the first YoY cement volume increase in six quarters, government-spending-led); the US is mid-to-late with soft residential (management does not expect a single-family recovery before 2027) but strong infrastructure (IIJA ~50% spent, peak spending expected in 2026 — with the authorization expiring 2026-09-30); Europe is weak-to-recovering (Spain +16% consumption, Germany +5.7% volume, UK import-contested and soft). [F]

External environment vs. internal actions? Both, and management is unusually explicit about the split. Project Cutting Edge delivered $200M of recurring savings in 2025 (target raised to $400M run-rate by 2027; ~45% of Q1’26 incremental like-for-like EBITDA), and the FY25 cost base fell ~$100M despite inflation. [F] Against that, the peso moved from a ~$65M EBITDA headwind (Q1’25) to a tailwind (Q1’26: +11% USD-reported sales vs +3% like-for-like), and management’s disclosed sensitivity — ~$75–80M of EBITDA per peso of appreciation — makes FX the largest single swing on the 2026 guide (assumed MXN 18.25–18.50; spot materially stronger). [F] Roughly: the margin story is internal; the translation story is external. [I]

Revenue stability? Low-to-moderate. Revenue plateaued at ~$16B for three years (2023–25), but that flat line conceals offsetting volume declines and price/mix/FX noise; the five-year range is $14.4B–$16.5B. [F] Cement demand tracks construction, which tracks rates, government budgets, and confidence — deep cyclicality is a demand-side trait of the industry, not a fixable company flaw. [I]

Market outlook — growing or shrinking, domestic or international? Cemex is a multinational with a shrinking-volume/growing-price developed-market core. ACA forecasts US cement consumption -2.5% in 2026, turning positive 2027. [F] Mexico is guided to +2.5–3% demand in 2026 (management). [F] Europe is structurally over-capacitated (~205Mt EU+UK clinker capacity vs ~115–125Mt demand) with Cemex itself expecting 20–30% capacity rationalization over the next decade — a shrinking-supply, not growing-demand, story. [F] Portfolio direction: divesting EM cement platforms (DR, Panama, Guatemala, Philippines, partial Colombia) and buying US aggregates/building-products bolt-ons. [F]

3. Business Quality & Competitive Moat

Is the industry getting more or less competitive? Less, in the places that matter — with one caveat. Cement’s weight-to-value ratio caps the economic trucking radius (~200 miles/~300km per Cemex’s own disclosure; ready-mix ~1.5 hours; aggregates ~30–50 miles), so each consumption basin is a local oligopoly even though the global industry is fragmented. [F] Greenwald’s share-stability test passes: Mexico shares essentially unchanged for decades (Cemex ~50%; top-3 ~70%); Germany top-5 >95%; US regional positions change only by acquisition, and US capacity has been static for a decade (no greenfields). [F] In Europe, carbon regulation (EU ETS free-allocation phase-out 2026→2034 plus CBAM, live 2026-01-01) is functioning as a supply-side guillotine — Marathon’s “capital starvation via regulation” — favoring the lowest-carbon incumbent, which is Cemex Europe (582 vs ~625 kg CO2/t industry average, ~2.9M surplus EUAs covering emissions through 2029, company-estimated ~€200M value). [F/I] The caveat: Mexico’s oligopoly is adding measured brownfield capacity (Holcim Macuspana, Moctezuma Tepetzingo) into a demand downturn — the first real test of Mexican pricing discipline in years. [F/I]

Profitability? The segment margin spread maps directly onto moat strength: Mexico 32.8% EBITDA margin (Q1’26: 36.1%) vs US 19.6% vs Europe 15.0% (FY2025, external-revenue basis). [F] Consolidated operating ROIC is estimated at ~7.5% for 2025 (analyst estimate on 20-F inputs) — likely near or just below WACC, which is why management has shifted incentives to EBIT/FCF/ROIC-over-WACC metrics and targets a +170bps ROIC-WACC spread by 2027. [F/A] Returns are improving but this is not yet a high-return-on-capital franchise at the group level; Mexico is. [I]

Barriers to entry? Real and layered: local scale economies within the freight radius; quarry permits and reserves (~27-year aggregates reserve life, ~91-year cement raw-material reserves — permitting is the barrier that breaks the capital cycle, per the aggregates precedent); ~2-year plant build times; and in Mexico, a retail distribution moat — ~2/3 of demand is bagged cement for self-construction, served through Construrama (>5,000 stores), with the top-5 distributors only 14% of volume. [F] Mexico-specific import barriers: poor port infrastructure and mountains shielding interior markets. [F]

Is the business easily understood? Yes at the product level — rocks, powder, wet concrete, sold locally — and no at the financial level: an FPI reporting in USD under IFRS with hybrid notes in equity, recurring impairments, discontinued-operations noise, and two leverage definitions (1.63x covenant vs 2.26x fully loaded). [F/I]

Foreign low-cost labor threat? The sector analog is not labor but the import fringe: imports are ~24% of US cement supply (Turkey, Vietnam, Canada ~70% of imports; >20% via Houston/Galveston), which keeps coastal/Gulf markets contestable and is the structural reason US cement is a weaker moat than inland aggregates. [F] CBAM is Europe’s answer to the same problem, embedding an estimated €5–10/t cost on importers (management estimate). [F/A] Cemex plays both sides with 11 US deep-water import terminals. [F]

Do brands matter? In Mexico, genuinely: Tolteca/Monterrey/Maya brand families plus retail captivity support the 32.8% margin — rare for a commodity. [F/I] In the US and Europe, cement is a spec product; brands matter little. [I]

Nature of competition / switching costs? Local price-volume discipline among few players; switching costs are modest on the product but real in practice — a failed ready-mix pour is catastrophic for a contractor, so reliable just-in-time logistics and specification relationships create behavioral captivity. [I] Cemex Go (65% of sales transacted digitally) and an NPS of 75 are service-layer attempts to convert commodity relationships into captivity — incremental, not structural. [F/I]

4. Financial Condition & Balance Sheet

Off-recognized or under-recognized assets and liabilities?

• Assets: quarry reserves (78Mt cement capacity, 225 quarries, decades of reserve life) carried at cost, not replacement value — replacement with today’s permitting would cost multiples of book. [I] The ~2.9M-ton EUA surplus (~€200M at €71/t; €83.27/t spot 2026-07-20) is a company-estimated, largely unrecognized asset. [F/A] Mexican deferred-tax assets swing recognition year to year (the source of 6.8%→90.9%→48.8% effective-rate chaos). [F]
• Liabilities: $2.0B of subordinated notes (5.125%/7.200%) are classified in equity under IAS 32 — coupons of ~$127M/yr bypass interest expense; treat as debt-like (raters give partial equity credit; one $1.0B tranche was redeemed June 2026, another $1.0B issued June 2025). [F] IFRS-16 leases and securitized receivables add ~$1.8B of obligations beyond the $5,644M of stated debt — hence two net-debt figures: $3,822M (debt-only) vs $5,638M (incl. obligations), and covenant net debt implied at ~$5.0B. [F] Pension/defined-benefit liability ~$588M. [F] Negative working capital of $1,250M is deliberate strategy, not distress. [F] EC antitrust exposure is unquantifiable and unprovisioned at the Statement-of-Objections stage. [F]

Accounting conservatism? Mixed-to-conservative presentation, aggressive-structure legacy. [I] Positives: USD presentation since FY2019 (removes peso-translation opacity at the statement level); impairments taken repeatedly and early ($430M goodwill in Q4’25 — $307M US + $123M Colombia, ahead of the Colombia exit; total 2025 impairments $538M). [F] Cautions: reported net income is chronically distorted — FY25 controlling NI $960M vs continuing-ops NI of just $404M (the gap is the +$566M discontinued-operations result, mostly the DR gain); FY25 FCF +50% is an adjusted figure (excludes severance/discontinued items); $179M of Cutting Edge restructuring sits in “other expenses, net” and is added back in company framing. [F] Recurring impairment/restructuring noise is a Cemex pattern ($442M in 2022, $538M in 2025) — normalize EBITDA and FCF, never reported NI. [I]

CapEx intensity? Moderate and falling as a share of EBITDA: FY2025 capex $1,243M ≈ 0.96x D&A ($1,291M) and ~40% of Operating EBITDA, split $824M maintenance / $419M expansion; commitments ~$1,100M for 2026. [F] Maintenance capex ≈ 64% of D&A — the asset base is being held, not grown; expansion capex tilts to US aggregates ($531M of 2025 capex in the US). [F] Decarbonization capex runs ~$210M/yr (~16% of total). [F]

5. Capital Allocation & Management

FCF and its use? FY2025 FCF (CFO − capex, 20-F basis) ≈ $732M — a ~24% conversion of Operating EBITDA vs the 47% Sprint target for 2027 (the company’s adjusted “FCF from operations” was ~$1.4B at 46% conversion on its own definition). [F] Uses in 2026: dividend raised ~40% to $180M (≈25% of FY25 FCF), buyback activated (~$100M in Q1’26), bolt-on M&A (Omega, Couch), and continued deleveraging. [F] Cumulative cash returned 2024–26 (~$525M) is a small fraction of cumulative FCF — the program is more promise than track record, with 2026 the first year of real scale. [I]

Significant acquisitions recently? The story is divestment-led: ~$3.5B+ of announced exits 2022–26 — Costa Rica/El Salvador ($325M, +$240M gain), Neoris, Guatemala ($212M, +$163M), Philippines ($798M, −$119M), Dominican Republic ($928–950M, +$551M gain), Panama ($200M, −$63M), and partial Colombia (~$555M at ~10x 2025 EBITDA, $485M from Holcim, closing expected end-2026). [F] Acquisitions are deliberately small: Couch Aggregates (SE-US sand & gravel, control ~$46M all-in), Omega Products International (western-US stucco, ~$23M EBITDA, <7x post-synergy), RC-Baustoffe (German recycling). [F] Divest-at-10x / repurchase-at-~7x is mechanically accretive and management knows it. [I]

Buybacks? Executed only at depressed prices: ~$83M in the 2020 COVID trough (~$0.22/CPO-equivalent) and $110.9M in 2022 ($0.50/CPO) — shares cancelled; then zero in 2023–2025 despite $500M/yr authorizations, i.e., no buybacks to hit EPS targets at any price. [F] The current program: intent of up to $500M over three years, subject to annual shareholder approval (the AGM authorizes $500M/yr); ~$100M deployed Feb 10–25, 2026 at MXN ~21.6–22.2/CPO (78.8M CPOs, 0.543% of capital). [F]

Share issuance to insiders? No dilutive issuance pattern; equity comp runs through the RSIP (restricted stock, since 2009, four-year graded vesting, granted in ADSs) covering ~4,500 variable-comp participants; new Section 16 Forms 3/4 (effective for FPI officers from March 2026) show small compensation-related grants, not selling. [F] Directors plus senior management plus immediate families own ~2.82% collectively; no individual Zambrano holds ≥1% disclosed except David Manuel Martínez Guzmán (1.62%). [F]

Compensation policy? Aggregate board + senior-management comp: $56M paid / $60M granted in 2025; average ~$3.3M paid per senior manager. [F] Annual cash bonus historically on Cash Value Added with a CO2 modifier (±10%), 0–200% range; from 2026, transitioning to EBIT + FCF + CO2 with TSR as modifier; long-term Performance Plan pays 0–200% on three-year relative TSR vs seven global peers and the MSCI EM LatAm index. [F] The metric migration from CVA to EBIT/FCF/ROIC mirrors the strategic shift to per-share cash generation. [I] Disclosure is aggregate-only (no CD&A, no named-executive pay) — materially below US proxy standards. [F]

Motivations? Rogelio Zambrano Lozano is Executive Chairman with a family-linked board seat, but the family exercises influence through structure, not economics (no ≥5% family block): the CPO trust votes non-Mexican-held Series A shares with the Mexican majority, ADS holders direct only the B vote, and a bylaw requires board pre-approval for any ≥2% stake accumulation — a hard anti-takeover device. [F] Management’s operative narrative is the post-Rinker redemption arc: the 2007 top-of-cycle $14.25B all-debt Rinker acquisition, ~$19.25B peak debt in 2009, and a 15-year repair to investment grade (S&P BBB- Mar-2024, Fitch Apr-2024) without a dilutive equity raise. [F] CEO Jaime Muguiro (since 2025-04-01, ex-Cemex USA president, 25+ years inside) is running continuity-with-intensification — same framework as González, faster execution. [I] Minority ADR holders are structurally passengers; the mitigant is that incentives and behavior (trough-timed buybacks, cancelled shares, divestment discipline) have been aligned in practice. [I]

6. Valuation & Market Data

Is the stock an ADR? Yes. NYSE: CX is an ADS; 1 ADS = 10 CPOs; 1 CPO = 2 Series A + 1 Series B shares, so 1 ADS = 30 underlying shares. The CPO trust is registered holder of 99.99% of Series A and B shares. [F] Governance implication: Series A shares underlying CPOs held by non-Mexicans (including all ADS holders) are voted by the trustee in line with the majority of Mexican-held A shares; ADS holders can direct only the Series B vote. Combined with the 2% board-approval bylaw, control is anchored with Mexican A-share holders and the incumbent board. [F] Practical data implication: vendor per-share and EV fields conflate the ADS ratio — ROIC.ai’s market cap/EV for CX are ~16x too high and AZI’s valuation percentiles were corrupt; all sound multiples must be built from 1,450.8M ADS-equivalents × price + net debt. [F]

Dividend policy? “Formal and progressive”: $120M (2024) → $130M (2025) → $180M (2026, +~40%), paid in four quarterly installments from the CUFIN (no Mexican withholding); run-rate ~$0.125/ADS/yr ≈ 1.0% yield. [F] Stated goal: distribute 40–50% of available FCF by 2030 via dividends plus buybacks. [F]

Profitability? See the Business Overview section — 19.1% FY25 EBITDA margin, Mexico-led; ROE ~7.5% on controlling equity (flattered neither way; the $2B hybrids sit in equity with coupons bypassing NI). [F]

Is net income diverging from cash from operations? Yes, and favorably: FY2025 CFO of $1,975M vs reported controlling NI of $960M — and vs continuing-ops NI of only $404M. [F] The bridge: D&A of $1,291M; $538M of non-cash impairments sitting in continuing-ops earnings; and the +$566M discontinued-operations result (DR gain) whose cash arrives in investing flows ($965M of 2025 divestment proceeds), not CFO. [F] Add the ~$585M pretax FX swing in financial income (−$353M in 2024 to +$232M in 2025) and the conclusion is mechanical: NI understates cash generation in 2025 and overstates earnings quality in disposal years. [I]

Where does the stock sit vs its own history? On the rebuilt (share-count-corrected) series: EV/EBITDA 7.2x FY25 ≈ 80th percentile of ten year-ends; P/S 1.11x TTM and P/B 1.37x are at decade highs; ten-year medians are 6.57x / 0.64x / 0.89x. [F] Clean-2026E P/E ≈ 16–17x (analyst normalization; reported P/E is meaningless given impairment/disposal distortion). [A] Interpretation: the multiple rerating is statistically complete on sales and book; the market is paying a premium multiple on recovered earnings — the late-rerating signature. [I] Vs peers, CX trades at par with Heidelberg (~7.4x), ~1 turn under GCC (~7.9x), ~2–3 turns under Holcim (~9.5x), and a 50–60% discount to the US materials tier (AMRZ 13.4x, CRH 15.0x, VMC 17.5x, MLM 19.1x) — the residual discount being Mexico-proxy (largest factor loading: Country Mexico +1.07; nearest factor peers are Mexico ETFs), governance, and lower FCF conversion, not leverage. [F/I]

7. Risks & Downside

What would cause the stock to decline?

• Mexico/peso reversal — the dominant factor (Country: Mexico loading +1.07; Mexico = 46% of EBITDA). The 2024 template: election/judicial-reform fears plus tariff threats drove a −43% drawdown with no company-specific deterioration. [F] A peso move back toward 19+ removes the translation tailwind embedded in the guide. [I]
• Mexico recovery fails — if Q1’26’s government-program-led volume turn proves a blip against the 2H26 budget, a ~$200–300M EBITDA swing (~$1.4–2.2B of EV at 7x) is at stake. [A]
• US volume weakness extends — ACA already forecasts −2.5% for 2026; the IIJA authorization cliff (2026-09-30, ~$166B Highway Trust Fund gap) is the single largest swing into 2027. [F]
• Price-led model exhaustion — earnings rest on price-over-cost holding while volumes fall; Mexico brownfield capacity (Macuspana, Tepetzingo) and US competitive pockets (Houston, NorCal, Atlanta) are the first real tests. [F/I]
• Energy — mid-to-high-single-digit cost/ton inflation guided; ~60% hedged (secondary source); Iran-war exposure. [F/A]
• EC antitrust fine — Statement of Objections received 2026-07-21 on admixtures in France/Germany; Cemex states third-party admixture sales are “insignificant,” disagrees with the findings, and cannot yet assess materiality; even a $200–300M fine is ~1% of market cap. [F/A]
• Colombia closing fails or slips — ~$555M at ~10x assumed to close end-2026; ~2.3% of EV. [F]
• Double compression — with P/S and P/B at decade highs, a bear case hits multiple and earnings together, as in 2022 (−43%) and 2024 (−43%). [I]

Catastrophic loss risk? The historical record is sobering: max drawdown −94.5% in the GFC after the Rinker acquisition (peak debt ~$19.25B; ~$14B bank-debt restructuring in 2009), and −62.6% over the trailing five-year window (2021–22). [F] FX/devaluation history is embedded: MXN is ~27% of revenue and CX trades as a Mexico proxy. [F]

Chance of total loss? Near-nil at current leverage: 1.63x covenant (limit 3.75x; new $3.0B revolver), 2.26x fully loaded, BBB-/BBB- with a stated “solid BBB” aim, laddered maturities, $2.35B undrawn committed RCF, and demonstrated asset-sale optionality (Colombia at 10x while the equity trades at ~7x). [F] The realistic catastrophic scenario is not zero but a severe equity haircut in a Mexico macro/peso crisis of the 2024 type compounded by an earnings miss — the bear framing in the log’s scenario work is roughly −40% to −58% (4.5–5.5x × $2.9–3.0B EBITDA), which is a drawdown profile, not a solvency profile. [I]

8. Recent News & Events

Has the environment changed recently? How? Yes, on several axes:

• Management: CEO transition effective 2025-04-01 (Muguiro for González); a broader reshuffle including a new Chief Comptroller (Jul 2025). Project Cutting Edge launched with the change: $200M recurring savings delivered 2025, $400M run-rate targeted 2027. [F]
• Credit: investment-grade recovery completed in 2024 (S&P 2024-03-13, Fitch ~2024-04-30; Moody’s does not rate); S&P Mexican national scale raised to mxAAA (2025-09). 2026 liability management: Ps5.5B Cebures (Feb), $3.0B sustainability-linked revolver (May), $1.5B 5.750% 2036 notes (June), $1.0B 5.125% hybrid redeemed (June 26) — terming out at IG economics and simplifying the hybrid layer ahead of the September 2026 reset. [F]
• Capital returns regime change: dividend +40% to $180M (AGM 2026-03-26) and the buyback actually activated 2026-02-10 (~$100M in twelve sessions) after three years of zero execution. [F]
• Portfolio: Colombia partial divestment announced 2026-03-12 (~$555M, ~10x, close expected end-2026); Omega acquired (closed 2026-03-31); Couch consolidated at 79%. [F]
• Regulatory/macro: EC Statement of Objections on admixtures (France/Germany) disclosed 2026-07-21 — the day of this appendix; [F] USMCA not renewed at the July 1 joint review — in force but in limbo, bilaterals the week of July 20; [F] CBAM definitive regime live 2026-01-01 and EU ETS free-allocation phase-out begun — the supply-side moat mechanism in Europe; [F/I] Iran war (Feb 2026) lifting energy costs and rates. [F]
• Imminent catalyst: Q2 2026 results Thursday 2026-07-23, 11:00 ET. Watch: whether HSD EBITDA guidance absorbs peso strength; energy-cost language; US cement price realization post the April 1 +$8/t increase; buyback pace post-February; USMCA commentary; Colombia closing progress. [F]

Any accounting policy changes? None adverse identified. The structural changes are presentational and older: USD presentation since FY2019, and segment redefinition to the regional structure in FY2025. [F] The hybrid notes’ equity classification (IAS 32) and discontinued-operations presentation materially shape the statements as noted elsewhere in this appendix. [F] One reporting change of note: Section 16 insider reporting became effective for FPI officers/directors on 2026-03-18, so Cemex insider-transaction transparency improves prospectively (Forms 3/4 now exist for CX). [F]

New markets, facilities, or management? No genuinely new markets — the direction is fewer markets, deeper developed-market exposure (exit DR/Panama/Colombia-part; add US aggregates terminals, e.g., the $29M Tampa expansion opened May 2026; Omega’s western-US stucco platform). [F] Management: new CEO (Apr 2025) with a decentralized regional P&L redesign, asset-level performance reviews, and revamped KPIs (EBIT/FCF conversion/ROIC-over-WACC) tied to variable comp from January 2026. [F] The nearshoring narrative remains optionality rather than a booked growth driver — management explicitly excludes USMCA-resolution upside from guidance. [F/I]

Sources: the FY2025 Form 20-F (SEC, 2026-04-24), earnings 6-Ks and press-release exhibits (2025-02 → 2026-07), Q2/Q3/Q4-2025 earnings-call transcripts, CEMEX Day 2026 presentation (SEC exhibit, 2026-02-26), USTR USMCA statement (2026-07-01), USGS-derived industry data, and UNAM IIEC Mexico market analysis (2025-10-31). Full numbered bibliography: Appendix B.

APPENDIX B — Source Appendix

Research date: 2026-07-21 | All sources accessed 2026-07-21 unless noted.

1. SEC Filings (SEC EDGAR, CIK 0001076378)

1. Cemex FY2025 Form 20-F, filed 2026-04-24 (accession 0001193125-26-177605). https://www.sec.gov/Archives/edgar/data/1076378/000119312526177605/d120395d20f.htm — primary source for FY2025 financials, segments, ownership, comp, capex, leverage (1.63x covenant), impairments ($430M goodwill/$538M total), restructuring ($179M), discontinued ops, ADS/CPO structure, EPS, tariff/USMCA risk factors.
2. Cemex FY2024 Form 20-F, filed 2025-04-28. https://www.sec.gov/Archives/edgar/data/1076378/000119312525112905/d905381d20f.htm — FY2024 comparatives.
3. Cemex FY2023 Form 20-F, filed 2024-04-29. https://www.sec.gov/Archives/edgar/data/1076378/000119312524119054/d702816d20f.htm — capex series, leverage 2.84x/2.06x history, 2022 transactions.
4. Cemex FY2022 Form 20-F, filed 2023-05-01 (local mirror sources/20-F/2023-05-01_d401501d20f.htm) — CR/El Salvador sale, Operation Resilience, 2022 capex.
5. Cemex FY2021 Form 20-F, filed 2022-04-29 (local mirror sources/20-F/2022-04-29_d305933d20f.htm).
6. Q4/FY2025 results 6-K + press release (Ex-1), 2026-02-05. https://www.sec.gov/Archives/edgar/data/1076378/000119312526038378/d86596dex1.htm — FY25 sales $16,132M / EBITDA $3,080M / NI $960M; Q4 NI −$356M; FCF +50% adj.; buyback “up to US$500M over the next 3 years”; +40% dividend proposal.
7. Q1 2026 results 6-K + press release (Ex-1), 2026-04-23 (accession 0001193125-26-171726). https://www.sec.gov/Archives/edgar/data/1076378/000119312526171726/d147626dex1.htm — EBITDA $794M +34%, margin 19.8%, sales $4,019M, NI $228M −69%, Mexico EBITDA +47% ($453M), ~$100M buyback, HSD guidance reaffirmed. (Ex-2 results book, Ex-3 presentation, same accession.)
8. Q3 2025 press release (6-K exhibit), 2025-10-28. https://www.sec.gov/Archives/edgar/data/1076378/000119312525252140/d873920dex991.htm — EBITDA $882M +19%, margin 20.8%, PCE ~$90M in quarter.
9. Q2 2025 press release (6-K exhibit), 2025-07-24. https://www.sec.gov/Archives/edgar/data/1076378/000119312525163755/d22025dex991.htm — PCE targets raised ($200M 2025 / $400M 2027), EBITDA $823M, NI $318M.
10. Q1 2025 press release (6-K exhibit), 2025-04-28. https://www.sec.gov/Archives/edgar/data/1076378/000119312525098252/d126459dex1.htm — Muguiro debut, NI $734M (incl. $618M DR gain), initial PCE targets.
11. CEMEX Day 2026 presentation (6-K exhibit), 2026-02-26. https://www.sec.gov/Archives/edgar/data/1076378/000119312526073257/d117391dex1.htm — 2027 Sprint targets ($17.8B/$3.7B/$2.3B/ROIC +170bps/47% FCF conversion), leverage definition slide (2.26x = net debt + sub notes / EBITDA), EUA surplus ~2.9M/~€200M through 2029, CBAM ~€9/t advantage, US aggregates metrics, Omega terms.
12. CEMEX Day 2026 press release (6-K Ex-99.1), 2026-02-26. https://www.sec.gov/Archives/edgar/data/1076378/000119312526077246/d118964dex991.htm.
13. Colombia partial divestment 6-K + press release, 2026-03-12. https://www.sec.gov/Archives/edgar/data/1076378/000119312526102954/d71639dex991.htm — ~$555M at ~10x 2025 EBITDA; $485M Holcim tranche; close expected end-2026.
14. EC Statement of Objections 6-K, 2026-07-21 (dated/signed 2026-07-20). https://www.sec.gov/Archives/edgar/data/1076378/000119312526309325/d255103d6k.htm — admixtures antitrust SO, France/Germany; “insignificant third-party sales”; outcome/materiality not assessable.
15. 2026 AGM resolutions 6-K, 2026-03-27. https://www.sec.gov/Archives/edgar/data/1076378/000119312526129025/d19444d6k.htm — $180M dividend; $500M repurchase re-authorization to 2027 AGM; board slate.
16. Dividend mechanics 6-Ks: 2026-02-27 (d119069d6k.htm, 4th FY25 installment; ADS=10 CPOs), 2026-06-05 (d160349d6k.htm, CPO structure), 2026-06-16 (d128666d6k.htm, first $45M installment paid 2026-06-18, coupon 159, FX 17.2023). All under https://www.sec.gov/Archives/edgar/data/1076378/.
17. Q2 2026 results scheduling 6-K, 2026-07-17 (d149288d6k.htm) — Q2’26 print due 2026-07-23.
18. Buyback daily-report 6-Ks, 2026-02-11 → 2026-02-26 (12 filings; activation d35487d6k.htm; e.g., d897767d6k.htm, d838031d6k.htm) — ~$99.9M CPOs repurchased Feb 10–25, 2026. Local mirror sources/6-K/.
19. Debt/financing 6-Ks: 2025-04-01 (d900564d6k.htm, $1.0B 9.125% subs redemption); 2025-06-05/10 (d941649d6k.htm, d24039d6k.htm, $1.0B subordinated perpetual-style notes); 2026-05-28 (d102228d6k.htm, $3.0B sustainability-linked revolver, 3.75x covenant); 2026-06-03/05 (d39579d6k.htm, d139221d6k.htm, $1.5B 5.750% senior notes due 2036); 2026-06-11 (d108327d6k.htm, $1.0B 5.125% subs call, redeemed 2026-06-26); 2025-09-04 (d26822d6k.htm, S&P mxAAA national-scale).
20. 424B2 prospectus supplement ($1.5B 2036 notes), 2026-06-01. https://www.sec.gov/Archives/edgar/data/1076378/000119312526257354/d52318d424b2.htm — reaffirms FPI status.
21. Section 16 filings (new post-HFIAA): ~25 Form 3s filed 2026-03-13/17 (initial ownership, officers/directors); Form 4 cluster Apr–Jul 2026 (e.g., J. Martínez Merla, Chief Comptroller, 2026-07-02, https://www.sec.gov/Archives/edgar/data/1076378/000209736826000003/xslF345X06/primary_doc.xml — RSIP award grants, not open-market trades); Form 3/As. NOTE: Section 16(a) applied to FPI directors/officers only from 2026-03-18 (HFIAA); 10% owners exempt; no 16(b). Pre-March-2026 insider data does not exist for CX.
22. Form 144 (Jesús Vicente González Herrera, 35,000 ADRs ~$425.6k), 2026-04-28. https://www.sec.gov/Archives/edgar/data/1076378/000195004726003802/primary_doc.xml (1 of 10 Form 144s 2024–2026, small affiliate sales).
23. SC 13G/A BlackRock (8.5%, pos. 2025-03-31) and SC 13G Dodge & Cox (6.6%, pos. 2025-06-30) — as summarized in FY2025 20-F Item 7 (filer-side submissions not in the issuer corpus).
24. Historical: Cemex 6-K, Aug 2009 — total debt ~$19,250M at 2009-06-30. https://www.sec.gov/Archives/edgar/data/1076378/000119312509195222/dex1.htm; Cemex 6-K, 2010 — Australia sale A$2.02B. https://www.sec.gov/Archives/edgar/data/1076378/000119312510065014/dex1.htm.

2. Regulatory / Official

25. USTR, “Ambassador Greer Issues Statement on the USMCA Joint Review,” 2026-07-01. https://ustr.gov/about/policy-offices/press-office/press-releases/2026/july/ambassador-greer-issues-statement-usmca-joint-review — USMCA not renewed; remains in force; bilaterals week of July 20, 2026.
26. S&P Global Ratings, “Cemex S.A.B. de C.V. Upgraded To ‘BBB-’ From ‘BB+’,” 2024-03-13. https://www.spglobal.com/ratings/en/regulatory/article/-/view/type/HTML/id/3138194.
27. S&P Global Ratings, issue rating BBB- on $1.5B 2036 notes, 2026-06-01. https://www.spglobal.com/ratings/en/regulatory/article/-/view/type/HTML/id/3572208.
28. American Cement Association (formerly PCA), Spring 2026 Forecast press release, 2026-04-30. https://www.cement.org/2026/04/30/aca-spring-forecast-2026/ — US cement consumption −2.5% 2026, positive 2027.
29. USGS Mineral Commodity Summaries data, republished by Concrete Financial Insights (third-party republisher of USGS data), accessed 2026-07-21. https://concretefinancialinsights.com/us-cement-industry-data — 114.1M ST shipments 2025 (−2%, −18% vs 2005 peak); imports 27M ST = 24% of supply; Turkey/Vietnam/Canada ~70%; ~$17B mill-net.
30. trade.gov (ITA), Mexico country commercial guide, 2026-02-17 — 2025 Mexican federal budget −14% real.
31. EU carbon market data: Trading Economics EU Carbon Permits (EUA €83.27/t, 2026-07-20). https://tradingeconomics.com/commodity/carbon; ICAP EU ETS page (accessed 2026-07-17); CBAM first certificate price €75.36/t Q1-2026 via cognitud.com (2026-04-09) and welhunt.com (2026-05-05) — trade-press secondary for CBAM pricing.
32. Credit Derivatives Determinations Committee, Final CEMEX Brief, 2009-03-09. https://www.cdsdeterminationscommittees.org/companies/cemex/docs/Final CEMEX Brief.pdf — 2009 restructuring of ~$14B of $15.1B bank debt.
33. Kleinberg Kaplan client alert, 2026-01-16. https://www.kkwc.com/insights/section-16-reporting-will-apply-to-directors-and-officers-of-foreign-private-issuers-beginning-march-18-2026/; Mintz, 2025-12-22. https://www.mintz.com/insights-center/viewpoints/2901/2025-12-22-section-16-insider-reporting-apply-foreign-private — HFIAA Section 16(a) effectiveness 2026-03-18.

3. Earnings-Call Transcripts

34. Cemex Q4 2025/FY25 earnings call, 2026-02-05 — transcript via ROIC.ai data service. Source of 2026 HSD guidance, FX assumption/sensitivity, 2.26x leverage definition, $183M severance (cash), $500M/3-yr buyback, pricing detail.
35. Cemex Q3 2025 earnings call, 2025-10-28 — transcript via ROIC.ai data service.
36. Cemex Q2 2025 earnings call, 2025-07-24 — transcript via ROIC.ai data service.
37. Cemex Q4 2024 earnings call, Feb 2025 — via stockinsights.ai (third-party transcript). https://www.stockinsights.ai/us/CX/earnings-transcript/fy24-q4-a879 — initial Cutting Edge framing ($150M/$350M).
38. GAP: Q1 2026 call (2026-04-23) transcript NOT available via ROIC.ai (verified 2026-07-21: latest ROIC transcript = Q4 2025). Q1’26 headline numbers verified against the SEC-filed press release (source 7); call color relies on secondary summaries (sources 46–48). Machine transcripts also mislabel CEO as “Jaime Dominguez” (correct: Jaime Muguiro).

4. Company Materials (cemex.com, non-SEC)

39. Cemex 1Q26 Report, 2026-04-23. https://www.cemex.com/documents/d/cemex/1q26-report-eng — Q1’26 results detail (leverage/buyback tables image-based).
40. Cemex dividend history page (accessed 2026-07-21). https://www.cemex.com/investors/stock-information/dividends — 2019 $150M / 2024 $120M / 2025 $130M / 2026 $180M; CUFIN sourcing.
41. Cemex credit ratings page (update dated 2025-09-01). https://www.cemex.com/en/investors/debt-information/credit-ratings — BBB-/BBB- Stable; S&P/Fitch only (no Moody’s).
42. Cemex 2020 Integrated Report. https://www.cemex.com/documents/20143/52528892/IntegratedReport2020.pdf — no dividends FY2016–2018.
43. Cemex 2024 Integrated Report release, 2025-03-25 — IG recovery by S&P and Fitch; highest FCF after maintenance capex since 2017.
44. Cemex press releases: “Cemex Announces CEO Transition,” 2025-02-10 (https://www.cemex.com/w/cemex-announces-ceo-transition); “Fitch Ratings Upgrades Cemex to Investment Grade,” 2024-04-30 (https://www.cemex.com/w/fitch-ratings-upgrades-cemex-to-investment-grade); “CEMEX Upgraded by S&P Global Ratings,” 2024-03 (https://www.cemex.com/w/cemex-upgraded-by-s-p-global-ratings); “CEMEX offers to acquire Rinker for US$12.8 billion,” Oct 2006 (https://www.cemex.com/w/cemex-offers-to-acquire-rinker-for-us-12-8-billion); Fairborn divestment PR (https://www.cemex.com/w/cemex-announces-divestment-of-its-fairborn-cement-plant-in-the-us); Kosmos divestment PR (https://www.cemex.com/w/cemex-announces-divestment-of-kentucky-cement-plant-and-related-assets-in-the-us).
45. Cemex IR events calendar (accessed 2026-07-21). https://www.cemex.com/en/investors — Q2 2026 webcast 2026-07-23 11:00 ET.

5. Data Services (all third-party — not primary; caveats noted)

46. ROIC.ai MCP (financials, transcripts, prices, news for CX), pulled 2026-07-21. CAVEATS: EV and market-cap fields for CX are corrupt (FY2025 mkt cap $300.6B / EV $305.9B, ~16x — share-count×ADS-price conflation; re-verified); FY2025 capex field corrupt ($265M vs 20-F $1,243M) and FY2023 capex understated; 2014–2016 rows mislabeled MXN but are USD; 2015/2017 capex and 2017 equity fields corrupt. Revenue/EBITDA/net-debt series do match the 20-F. News feed for ticker “CX” heavily contaminated with “customer experience” articles.
47. FactorsToday API (factor loadings, leaderboard, stock-info, related-stocks, specific-vol, factor-returns), pulled 2026-07-21, model date 2026-07-20. Third-party computation; CX covered despite ADR status; rs_peak inconsistent with AZI lifetime high (ADR-ratio artifact).
48. AZI Trading price-history CSV (adjusted/unadjusted OHLCV, EMAs, beta). https://azitrading.com/controls/download-data.php?t=CX, pulled 2026-07-21. Close $12.49 (2026-07-20) vs ROIC $12.66 — ~1.4% discrepancy; lifetime $72.08 high (2006) is an unadjusted-history artifact.
49. SEC EDGAR XBRL companyconcept API (ifrs-full tags) — currency-presentation history (MXN→USD from FY2019 20-F); revenue/CFO cross-check.

6. News / Trade Press

50. Morningstar/Dow Jones, “Cemex Reports Solid 1Q Sales, Ebitda Growth,” 2026-04-23. https://www.morningstar.com/news/dow-jones/202604236789/cemex-reports-solid-1q-sales-ebitda-growth.
51. Global Cement, “Cemex reports earnings growth in first quarter of 2026,” 2026-04-24. https://www.globalcement.com/news/20692-cemex-reports-earnings-growth-in-first-quarter-of-2026.
52. Rock Products, “Cemex U.S. Business Grows Despite Adverse Weather,” 2026-04-29. https://rockproducts.com/2026/04/29/cemex-u-s-busines-grows-despite-adverse-weather/.
53. TipRanks company-announcement summaries: Q1’26 (2026-04-23, https://www.tipranks.com/news/company-announcements/cemex-delivers-record-q1-2026-ebitda-as-transformation-plan-drives-cash-flow-and-payouts); AGM approval (2026-03-27, https://www.tipranks.com/news/company-announcements/cemex-shareholders-approve-2025-results-us180-million-dividend-and-us500-million-buyback-capacity). Secondary aggregator.
54. MENAFN/Rio Times, Q1’26 coverage, 2026-04-23. https://menafn.com/1111024727/ — secondary; its “−67%” NI decline is contradicted by the PR exhibit (−69%).
55. Alpha Spread, CX investor-relations summary (accessed 2026-07-21). https://www.alphaspread.com/security/nyse/cx/investor-relations — Q1’26 call color (energy hedging ~60%, Omega ~$23M EBITDA/synergies). SECONDARY, unverified against primary transcript.
56. Business Wire (company releases): “Cemex to Divest a Part of Its Operations in Colombia,” 2026-03-11 (https://www.businesswire.com/news/home/20260311128340/en/); “Cemex to Acquire Omega Products International,” 2026-02-26 (https://www.businesswire.com/news/home/20260226653680/en/); “Cemex Announces Pricing of U.S.$1.5 Billion of 5.750% Senior Notes Due 2036,” 2026-06-02 (https://www.businesswire.com/news/home/20260602427354/en/); “Cemex Receives MSCI ESG Rating Upgrade to AAA,” 2026-03-24 (https://www.businesswire.com/news/home/20260324634029/en/).
57. CemNet: “Cemex reports strong 3Q25 results with record margins,” 2025-10-29 (https://www.cemnet.com/News/story/180174/); “CEMEX upgraded by Fitch Ratings,” 2024-05-02 (https://www.cemnet.com/News/story/176938/); CEMEX Day FCF-conversion coverage (https://www.cemnet.com/News/story/180885/).
58. World Cement, “Cemex delivers double-digit EBITDA growth…,” 2025-10-29. https://www.worldcement.com/the-americas/29102025/.
59. Global Cement, “S&P upgrades Cemex to investment grade (BBB-),” 2024-03-14. https://www.globalcement.com/news/item/17102-s-p-upgrades-cemex-to-investment-grade; cbonds (S&P BBB- affirmation, 2025-03-27).
60. Pit & Quarry, “Muguiro Officially Takes Reins as Cemex CEO,” 2025-04-01. https://www.pitandquarry.com/muguiro-officially-takes-reins-as-cemex-ceo/; Concrete Products, 2014-06-03 (González/R. Zambrano appointments).
61. Rinker-era coverage: Daily Reporter, 2007-06-11 ($14.25B accepted); ENR, 2007-06-10 (net debt $5.1B Mar-2007). https://dailyreporter.com/2007/06/11/cemex-wins-controlling-stake-in-rinker/ ; https://www.enr.com/articles/31965.
62. Eagle Materials PR, Kosmos Cement acquisition ($665M), 2019-11-26. https://ir.eaglematerials.com/news-releases/news-release-details/eagle-materials-inc-announces-agreement-acquire-kosmos-cement.
63. CreditSights, “Cemex Spotlight — Tariffs, Hybrids and New CEO,” 2025-03-04. https://know.creditsights.com/insights/cemex-spotlight-tariffs-hybrids-and-new-ceo/ — ratings NR/BBB-/BBB- (Moody’s NR), ~1.8x YE24 leverage. Subscription research, third-party.
64. Mexico demand/structure: UNAM IIEC, “La industria del cemento en México,” 2025-10-31 (https://www.probdes.iiec.unam.mx/index.php/pde/article/view/56775/62590 — Cemex ~50% share); Forbes México (top-3 ~70%); ResearchAndMarkets via Business Wire, 2025-07-24 (construction −5.9% real 2025); Mexico Business News, 2026-07-13 (https://mexicobusiness.news/infrastructure/news/mexico-construction-contracts-37-recovery-expected-2h26); Expert Market Research, 2026-06-10 (~47Mt market).
65. Market/positioning: defenseworld.net, “Short Interest in Cemex Increases By 57.8%,” 2026-04-14; GuruFocus, 2026-06-11 (+7.6% day; 52-wk range figure conflicts with AZI); Zacks, 2026-06-11; Seeking Alpha, “Top Latin American Stocks,” 2026-02-08; vallartadaily.com, 2025-03-04 (peso); Investing.com (CEO transition 2025-02-10; buyback 6-K coverage 2026-02); Simply Wall St management profile.
66. AInvest, “Cemex Q1 2026 Record EBITDA… Analysts Split,” 2026-04-23. https://www.ainvest.com/news/cemex-q1-2026-record-ebitda-validates-transformation-analysts-split-growth-sustainability-2604/ — LOW-RELIABILITY aggregator; sentiment dispersion only ($10.14 consensus target is stale).
67. Decarbonization context: WEF, 2024-09-13 (cement ~8% of CO2, https://www.weforum.org/stories/2024/09/cement-production-sustainable-concrete-co2-emissions/); ScienceDirect, 2025-03-13 (7–8%); intellectia.ai, 2026-01-08 (MXN/EM); openPR US cement report, 2026-07-16 (California Buy Clean).
68. BSI, “USMCA review — what you need to know before July 2026,” 2026-07-01 (Mexico/Canada tariff exemption); El CEO, 2026-02-12 (Muguiro first-year profile).